<SEC-DOCUMENT>0001144204-14-035896.txt : 20140624
<SEC-HEADER>0001144204-14-035896.hdr.sgml : 20140624
<ACCEPTANCE-DATETIME>20140605160218
ACCESSION NUMBER:		0001144204-14-035896
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20140605
DATE AS OF CHANGE:		20140605

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HUDSON TECHNOLOGIES INC /NY
		CENTRAL INDEX KEY:			0000925528
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-MACHINERY, EQUIPMENT & SUPPLIES [5080]
		IRS NUMBER:				133641539
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-185490
		FILM NUMBER:		14893696

	BUSINESS ADDRESS:	
		STREET 1:		PO BOX 1541
		STREET 2:		ONE BLUE HILL PLAZA, 14TH FLOOR
		CITY:			PEARL RIVER
		STATE:			NY
		ZIP:			10965
		BUSINESS PHONE:		8457356000

	MAIL ADDRESS:	
		STREET 1:		PO BOX 1541
		STREET 2:		ONE BLUE HILL PLAZA, 14TH FLOOR
		CITY:			PEARL RIVER
		STATE:			NY
		ZIP:			10965

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	REFRIGERANT RECLAMATION INDUSTRIES INC
		DATE OF NAME CHANGE:	19940617
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>v380784_424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed pursuant to Rule 424(b)(5)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-185490</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #C00000"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #C00000"><B>This preliminary prospectus supplement relates
to an effective registration statement under the Securities Act of 1933, but is not complete and may be changed. This preliminary
prospectus supplement and the accompanying prospectus are not an offer to sell these securities and we are not soliciting offers
to buy these securities in any jurisdiction where the offer or sale is not permitted. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #C00000; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #C00000">SUBJECT TO COMPLETION, DATED
JUNE 5, 2014</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #C00000">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PROSPECTUS SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(To prospectus dated January 22, 2013)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="tlogo42.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Hudson
Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 15%; color: black">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are offering shares of our common stock
pursuant to this prospectus supplement and the accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our common stock is traded on the NASDAQ
Capital Market under the symbol &ldquo;HDSN.&rdquo; On June 4, 2014, the last reported sale price of our common stock on the NASDAQ
Capital Market was $2.76. The aggregate market value of our outstanding common stock held by non-affiliates is $61,910,316, based
on 25,131,426 shares of outstanding common stock on May 5, 2014, of which 18,704,023 shares are held by non-affiliates, and a per
share price of $3.31 based on the closing sale price of our common stock on May 5, 2014. We have not offered or sold any securities
during the prior 12 calendar month period that ends on, and includes, the date of this prospectus supplement,&nbsp;pursuant to
General Instruction I.B.6. of Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Investing in our common stock involves
a high degree of risk.&nbsp;&nbsp;See &ldquo;Risk Factors&rdquo; beginning</B> <B>on page&nbsp;S-3 of this prospectus supplement
to read about factors you should consider before buying any shares.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 76%; border-top: Black 1.5pt double; border-bottom: Black 1pt solid">&nbsp;</td>
    <TD STYLE="width: 12%; border-top: Black 1.5pt double; border-bottom: Black 1pt solid">&nbsp;</td>
    <TD STYLE="width: 12%; border-top: Black 1.5pt double; border-bottom: Black 1pt solid">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid">&nbsp;</td>
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid"><b><u>Per Share</u></b></td>
    <TD NOWRAP STYLE="border-bottom: Black 1pt solid"><b><u>&nbsp;&nbsp;Total&nbsp;&nbsp;</u></b></td></tr>
<tr>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid">Public offering price</td>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">$</td>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid">$</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">Underwriting discounts and commissions(1)</td>
    <TD STYLE="border-bottom: Black 1pt solid">$</td>
    <TD STYLE="border-bottom: Black 1pt solid">$</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt double">Proceeds, before expenses, to us</td>
    <TD STYLE="border-bottom: Black 1.5pt double">$</td>
    <TD STYLE="border-bottom: Black 1.5pt double">$</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 5%">(1)</td>
    <td style="width: 2%">&nbsp;</td>
    <td style="width: 93%">See <font style="font-family: Times New Roman, Times, Serif">&ldquo;</font>Underwriting<font style="font-family: Times New Roman, Times, Serif">&rdquo;</font>beginning on page S-8 for a description of the compensation payable to the underwriters.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement
is accurate or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have granted the underwriters an option
for a period of 30&nbsp;days to purchase up to an additional shares of our common stock solely to cover over-allotments, if any.
If the underwriters exercise the option in full, the total public offering price will be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
the total underwriting discounts and commissions payable by us will be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
and our total proceeds, before expenses, will be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. Delivery of the
shares of common stock is expected to be made on or about , 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Sole Book-Running Manager</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>William
Blair</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Co-Managers</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 45%; font-weight: bold; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Craig-Hallum
    Capital Group </B></FONT></td>
    <TD STYLE="width: 10%; font-weight: bold; text-align: center"><B>&nbsp;</B></td>
    <TD STYLE="width: 45%; font-weight: bold; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Roth
    Capital Partners </B></FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus supplement is
June , 2014</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 89%; padding-bottom: 1pt"><b>&nbsp;</b></td>
    <TD STYLE="width: 11%; text-align: right; border-bottom: Black 1pt solid"><B>Page</B></td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><b>Prospectus Supplement</b></td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <td><A HREF="#hti_001">ABOUT THIS PROSPECTUS SUPPLEMENT</A></td>
    <td style="text-align: right">i</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <td><A HREF="#hti_002">PROSPECTUS SUPPLEMENT SUMMARY</A></td>
    <td style="text-align: right">S-1</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <td><A HREF="#hti_003">RISK FACTORS</A></td>
    <td style="text-align: right">S-3</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <td><A HREF="#hti_004">FORWARD-LOOKING STATEMENTS</A></td>
    <td style="text-align: right">S-4</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <td><A HREF="#hti_005">USE OF PROCEEDS</A></td>
    <td style="text-align: right">S-5</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <td><A HREF="#hti_006">DILUTION</A></td>
    <td style="text-align: right">S-6</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <td><A HREF="#hti_007">DESCRIPTION OF THE SECURITIES WE ARE OFFERING</A></td>
    <td style="text-align: right">S-6</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <td><A HREF="#hti_008">UNDERWRITING</A></td>
    <td style="text-align: right">S-8</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <td><A HREF="#hti_009">LEGAL MATTERS</A></td>
    <td style="text-align: right">S-11</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <td><A HREF="#hti_010">EXPERTS</A></td>
    <td style="text-align: right">S-11</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <td><A HREF="#hti_011">WHERE YOU CAN FIND MORE INFORMATION</A></td>
    <td style="text-align: right">S-11</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <td><A HREF="#hti_012">INFORMATION INCORPORATED BY REFERENCE</A></td>
    <td style="text-align: right">S-11</td></tr>
</table>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="hti_001"></A>ABOUT THIS
PROSPECTUS SUPPLEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A registration statement on Form S-3 (File
no. 333-185490) utilizing a shelf registration process relating to the securities described in this prospectus supplement was initially
filed with the Securities and Exchange Commission, or the SEC, on December 14, 2012 and, as amended, was declared effective on
January 22, 2013.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This document is in two parts.&nbsp;&nbsp;The
first part is this prospectus supplement, which describes the terms of this offering of our common stock and also adds, updates
and changes information contained in the accompanying prospectus and the documents incorporated by reference.&nbsp;&nbsp;The second
part is the accompanying prospectus, which gives more general information, some of which may not apply to this offering.&nbsp;&nbsp;To
the extent the information contained in this prospectus supplement differs or varies from the information contained in the accompanying
prospectus or any document filed prior to the date of this prospectus supplement and incorporated by reference, the information
in this prospectus supplement will control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should rely only on the information
contained in or incorporated by reference into this prospectus supplement and the accompanying prospectus.&nbsp;&nbsp;We have not,
and the underwriters have not, authorized anyone to provide you with information that is different.&nbsp;&nbsp;This prospectus
supplement is not an offer to sell or solicitation of an offer to buy these securities in any circumstances under which the offer
or solicitation is unlawful.&nbsp;&nbsp;We are offering to sell, and seeking offers to buy, our securities only in jurisdictions
where offers and sales are permitted.&nbsp;&nbsp;You should not assume that the information we have included in this prospectus
supplement or the accompanying prospectus is accurate as of any date other than the date of this prospectus supplement or the accompanying
prospectus, respectively, or that any information we have incorporated by reference is accurate as of any date other than the date
of the document incorporated by reference, regardless of the time of delivery of this prospectus supplement and the accompanying
prospectus or of any of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We obtained the industry and market data
in this prospectus supplement, the accompanying prospectus and the incorporated documents from our own research as well as from
industry and general publications, surveys and studies conducted by third parties. These data involve a number of assumptions and
limitations, and you are cautioned not to give undue weight to such data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="hti_002"></A>PROSPECTUS
SUPPLEMENT SUMMARY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>This summary highlights information contained
elsewhere or incorporated by reference</I> <I>into this prospectus supplement and accompanying prospectus. This summary does not</I>
<I>contain all of the information that you should consider before investing in our securities. You should carefully read the entire
prospectus supplement and the</I> <I>accompanying prospectus, including the &ldquo;Risk Factors&rsquo; section, starting on</I>
<I>page&nbsp;S-3 of this prospectus supplement, as well as the financial statements</I> <I>and the other information incorporated
by reference herein before making an</I> <I>investment decision. In this prospectus supplement and the accompanying prospectus,
reference so &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; and the &ldquo;Company&rdquo; refer to Hudson Technologies,
Inc. and its consolidated subsidiaries.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are a refrigerant services company providing
innovative solutions to recurring problems within the refrigeration industry.&nbsp;&nbsp;Our products and services are primarily
used in commercial air conditioning, industrial processing and refrigeration systems, and include (i) refrigerant sales, (ii) refrigerant
management services consisting primarily of reclamation of refrigerants and (iii) RefrigerantSide&reg; Services performed at a
customer's site, consisting of system decontamination to remove moisture, oils and other contaminants.&nbsp; We operate principally
through our wholly-owned subsidiary, Hudson Technologies Company.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We sell reclaimed and virgin (new) refrigerants
to a variety of customers in various segments of the air conditioning and refrigeration industry. We continue to sell reclaimed
chlorofluorocarbon, or CFC, based refrigerants, which are no longer manufactured, as well as virgin, non-CFC based refrigerants,
including hydrochlorofluorocarbon, or HCFC, and hydrofluorocarbon, or HFC, refrigerants, which are purchased by us from several
suppliers and resold by us, typically at wholesale.&nbsp;&nbsp; Additionally, we regularly purchase used or contaminated CFC, HCFC
and HFC refrigerants from many different sources, which refrigerants are then reclaimed using our high speed proprietary Zugibeast&reg;
reclamation system, and then are resold by us.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We provide a complete offering of refrigerant
management services, which primarily include reclamation of refrigerants, laboratory testing through our laboratory, which has
been certified by the Air Conditioning, Heating and Refrigeration Institute, and refrigerant banking (storage) services tailored
to individual customer requirements.&nbsp; We also separate &ldquo;crossed&rdquo; (<I>i.e</I>., commingled) refrigerants and provide
re-usable cylinder refurbishment and hydrostatic testing services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We provide decontamination and recovery
services that are performed at a customer's site through the use of portable, high volume, high-speed proprietary equipment.&nbsp;
Certain of these RefrigerantSide&reg; Services, which encompass system decontamination, and refrigerant recovery and reclamation,
are also proprietary and are covered by process patents. In addition, RefrigerantSide&reg; Services include predictive and diagnostic
services for industrial and commercial refrigeration applications, which are designed to predict potential catastrophic problems
and identify inefficiencies in an operating system. Our Chiller Chemistry&reg;, Chill Smart&reg;, Fluid Chemistry&reg; and Performance
Optimization are predictive and diagnostic service offerings. Our SmartEnergy OPS&trade; service is a web-based real time continuous
monitoring service applicable to a facility&rsquo;s refrigeration systems and other energy systems.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a component of our products and services,
we also participate in the generation of carbon offset projects.<I>&nbsp;</I>CFC refrigerants are ozone depleting substances and
are also highly weighted greenhouse gases that contribute to global warming and climate change.&nbsp; The destruction of CFC refrigerants
may be eligible for verified emission reductions that can be converted and monetized into carbon offset credits that may be traded
in the emerging carbon offset markets.&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Corporate Information</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We were organized as a New York corporation
in January 1991. Our principal executive offices are located at 1 Blue Hill Plaza, 14<SUP>th</SUP> floor<B>,</B> Pearl River, New
York 10965 and our telephone number is (845) 735-6000. We maintain an internet website at <I>http://www.hudsontech.com</I>. The
information on our website or any other website is not incorporated by reference into this prospectus supplement or the accompanying
prospectus and does not constitute a part of this prospectus supplement or the accompanying prospectus. Our Annual Report on Form&nbsp;10-K,
Quarterly Reports on Form&nbsp;10-Q and Current Reports on Form&nbsp;8-K and all amendments to such reports are made available
free of charge through the Investor Relations section of our website as soon as reasonably practicable after they have been filed
or furnished with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
</FONT>Offering</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 44%">Common stock offered by us</td>
    <TD STYLE="width: 56%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    shares of common stock (or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock if the underwriters
    exercise their option to purchase &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional shares in
    full).</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>Common stock to be outstanding after this offering</td>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock (or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock if the underwriters exercise their option to purchase &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional shares in full).</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>Over-allotment option</td>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>Use of proceeds</td>
    <TD>We expect the net proceeds from this offering will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million (or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million if the underwriters exercise their option to purchase additional shares in full) after deducting underwriting discounts and commissions, as described in &ldquo;Underwriting,&rdquo; and estimated offering expenses payable by us.&nbsp;&nbsp;We currently intend to use the net proceeds of this offering for working capital and general corporate purposes which may include, among other things, funding acquisitions, although we have no present commitments or agreements with respect to any such transactions.&nbsp;&nbsp;We may also use a portion of the proceeds to reduce or repay indebtedness under our loan agreement with our existing commercial lender.&nbsp;&nbsp;See <font style="font-family: Times New Roman, Times, Serif">&ldquo;</font>Use of Proceeds<font style="font-family: Times New Roman, Times, Serif">&rdquo;</font> on page&nbsp;S-5. </td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>Risk factors</td>
    <TD>See &ldquo;Risk Factors&rdquo; beginning on page&nbsp;S-3 for a discussion of factors you should consider carefully when making an investment decision.</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>NASDAQ Capital Market symbol</td>
    <TD>HDSN</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The number of shares of our common stock
to be outstanding immediately after the closing of this offering is based on 25,090,386 shares of common stock outstanding as of
March 31, 2014 and excludes, as of that date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>2,497,911 shares of common stock issuable upon the exercise of stock options outstanding prior to this offering under our stock
option plans and stock incentive plans, at a weighted average exercise price of $1.33 per share;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>2,521,733 shares of common stock available for future grants under our stock option plans and stock incentive plans; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>1,242,250 shares of common stock issuable upon the exercise of warrants outstanding prior to this offering, at a weighted average
exercise price of $2.53 per share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="hti_003"></A>RISK FACTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Before deciding to invest in our securities,
you should consider carefully the following discussion of risks and uncertainties affecting us and our securities, as well as the
risks and uncertainties incorporated by reference in this prospectus supplement and the accompanying prospectus from our Annual
Report on Form 10-K for the fiscal year ended December&nbsp;31, 2013 and our Quarterly Report on Form 10-Q for the period ended
March 31, 2014, respectively, and the other information contained or incorporated by reference in this prospectus supplement.&nbsp;&nbsp;If
any of the events anticipated by these risks and uncertainties occur, our business, financial condition and results of operations
could be materially and adversely affected, and the value of our securities could decline.&nbsp;&nbsp;The risks and uncertainties
we discuss in the documents incorporated by reference in this prospectus supplement and the accompanying prospectus are those that
we currently believe may materially affect our company.&nbsp;&nbsp;Additional risks and uncertainties not presently known to us
or that we currently deem immaterial also may materially and adversely affect our business, financial condition and results of
operations.&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Since we have broad discretion in how we use the proceeds
from this offering, we may use the proceeds in ways with which you disagree.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have not allocated specific amounts of
the net proceeds from this offering for any specific purpose.&nbsp;&nbsp;Accordingly, our management will have significant flexibility
in applying the net proceeds of this offering.&nbsp;&nbsp;You will be relying on the judgment of our management with regard to
the use of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the
proceeds are being used in ways you would agree with.&nbsp;&nbsp;It is possible that the net proceeds will be invested in a way
that does not yield a favorable, or any, return for our company.&nbsp;&nbsp;The failure of our management to use such funds effectively
could have a material adverse effect on our business, financial condition, operating results and cash flow.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">If you purchase the common stock sold in this offering
you will experience immediate and substantial dilution in your investment. You will experience further dilution if we issue additional
equity securities in future fundraising transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based on the public offering price of $
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share and our net tangible book value as of March&nbsp;31, 2014, if you purchase
shares of common stock in this offering, you will suffer immediate and substantial dilution of $ per share with respect to the
net tangible book value of the common stock. See the section titled &ldquo;Dilution&rdquo; in this prospectus supplement for a
more detailed discussion of the dilution you will incur if you purchase common stock in this offering.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Future sales of our common stock may cause the prevailing
market price of our shares to decrease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have issued a substantial number of shares
of common stock that are eligible for resale under Rule 144 of the Securities Act and may become freely tradable. We have also
registered 2,497,911 shares of common stock that are issuable upon the exercise of options and have registered 1,168,750 shares
of common stock that are issuable upon the exercise of warrants outstanding as of June 4, 2014. If the holders of our options and
warrants choose to exercise their purchase rights and sell the underlying shares of common stock in the public market, or if holders
of currently restricted shares of our common stock choose to sell such shares in the public market under Rule 144 or otherwise,
the prevailing market price for our common stock may decline. The sale of shares issued upon the exercise of our options and warrants
could also further dilute the holdings of our then existing shareholders. In addition, future public sales of shares of our common
stock could impair our ability to raise capital by offering equity securities.<B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The volume of our common stock has been, and may continue
to be, volatile, which could reduce the market price of our common stock.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The publicly traded shares of our common
stock have experienced, and may continue to experience, significant volume and price volatility. This volatility could reduce the
market price of our common stock, regardless of our operating performance. In addition, both the volume and the trading price of
our common stock could change significantly over short periods of time in response to, among other things, actual or anticipated
variations in our quarterly operating results, announcements by us and/or changes in national or regional economic conditions,
making it more difficult for shares of our common stock to be sold at a favorable price or at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="hti_004"></A>FORWARD-LOOKING
STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Some of the statements contained in this
prospectus supplement and accompanying prospectus or incorporated by reference into this prospectus supplement and accompanying
prospectus are forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, or
the Securities Act, and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and are subject
to the safe harbor created by the Securities Litigation Reform Act of 1995. We have based these forward-looking statements largely
on our expectations and projections about future events and financial trends affecting the financial condition and/or operating
results of our business. Words such as &ldquo;anticipates,&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo; &ldquo;plans,&rdquo;
&ldquo;believes,&rdquo; &ldquo;seeks,&rdquo; &ldquo;estimates,&rdquo; the negative of these words, or similar expressions are intended
to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to certain
risks, uncertainties and assumptions that are difficult to predict; therefore, actual results may differ materially from those
expressed or forecasted in, or implied by,&nbsp;any forward-looking statements. The risks and uncertainties include those noted
under the heading &ldquo;Risk Factors&rdquo; above, in the documents incorporated herein by reference and in the accompanying prospectus.
There are important factors which may cause our actual results, performance or achievements to be materially different from any
future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but
are not limited to, changes in the laws and regulations affecting the industry, changes in the markets for refrigerants (including
unfavorable market conditions adversely affecting the demand for, and the price of, refrigerants), our ability to source refrigerants,
regulatory and economic factors, seasonality, competition, litigation, the nature of supplier or customer arrangements that become
available to us in the future, adverse weather conditions, possible technological obsolescence of existing products and services,
possible reduction in the carrying value of long-lived assets, estimates of the useful life of its assets, potential environmental
liability, customer concentration, the ability to obtain financing, any delays or interruptions in bringing products and services
to market, the timely availability of any requisite permits and authorizations from governmental entities and third parties as
well as factors relating to doing business outside the United States, including changes in the laws, regulations, policies, and
political, financial and economic conditions, including inflation, interest and currency exchange rates, of countries in which
we may seek to conduct business, our ability to successfully integrate any assets it acquires from third parties into its operations,
and other risks detailed in &ldquo;Risk Factors&rdquo; above&nbsp;&nbsp;and in our periodic reports filed with the SEC that are
incorporated herein and in the accompanying prospectus by reference. Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date the statement was made.<B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We do not intend to update or revise any
forward-looking statements, whether as a result of new information, future events or otherwise. Past financial or operating performance
is not necessarily a reliable indicator of future performance, and you should not use our historical performance to anticipate
results or future period trends.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="hti_005"></A>USE OF PROCEEDS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We expect the net proceeds from this offering
to be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million (or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million if the underwriters
exercise their option to purchase &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional
shares in full), after deducting underwriting discounts and commissions, as described in &ldquo;Underwriting,&rdquo; and estimated
offering expenses payable by us. We currently intend to use the net proceeds of this offering for working capital and general corporate
purposes which may include, among other things, funding acquisitions, although we have no present commitments or agreements with
respect to any such transactions. We may also use a portion of the proceeds to reduce or repay indebtedness under our loan agreement,
which we refer to as the PNC Facility, with PNC Bank, National Association, our existing commercial lender. Interest charges under
the &nbsp;loans are equal to (A) with respect to domestic rate loans, the sum of (i) a rate per annum equal to the higher of (1)
the base commercial lending rate of PNC, (2) the federal funds open rate plus .5% and (3) the daily LIBOR plus 1%, plus (ii) .5%
and (B) with respect to Eurodollar rate loans, the sum of the Eurodollar rate plus 2.75%.&nbsp; The effective interest rate under
the PNC Facility was 3.0% at March 31, 2014, and the PNC Facility will expire&nbsp;on June 22, 2015, unless terminated sooner following
an event of default. See &ldquo;Part I - Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations-Liquidity
and Capital Resources&rdquo; of our Form 10-Q for the quarter ended March&nbsp;31, 2014, which is incorporated herein by reference,
for additional information regarding our indebtedness described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pending application of such proceeds, we
expect to invest the proceeds in short-term, interest bearing, investment-grade marketable securities or money market obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We cannot estimate precisely the allocation
of the net proceeds from this offering among these uses. The amounts and timing of the expenditures may vary significantly, depending
on numerous factors, including the amount of cash generated internally from operations and the terms and availability of&nbsp;financing
arrangements, as well as the amount of cash used in our operations. Our management will have broad discretion in the application
of the net proceeds of this offering.&nbsp;&nbsp;We reserve the right to change the use of proceeds as a result of certain contingencies
such as competitive or economic developments and other factors.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="hti_006"></A>DILUTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our net tangible book value on March&nbsp;31,
2014 was approximately $28.2 million, or approximately $1.13 per share of common stock. Net tangible book value per share is determined
by dividing our net tangible book value, which consists of tangible assets less total liabilities, by the number of shares of common
stock outstanding on that date. Without taking into account any other changes in the net tangible book value after March&nbsp;31,
2014, other than to give effect to our receipt of the estimated net proceeds from the sale of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
shares of our common stock at an offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of common stock, less the underwriting
fees and our estimated offering expenses, our as adjusted net tangible book value as of March&nbsp;31, 2014, after giving effect
to the items above, would have been approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per share of common stock. This represents an immediate increase in the net tangible book value of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
per share of common stock to existing stockholders and an immediate dilution of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share
of common stock to new investors. The following table illustrates this per share dilution:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%">Public offering price per share of common stock</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1%">&nbsp;</TD><TD STYLE="text-align: right; width: 10%"></TD><TD STYLE="text-align: left; width: 1%">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1%">$</TD><TD STYLE="text-align: right; width: 10%"></TD><TD STYLE="text-align: left; width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Net tangible book value per share as of March&nbsp;31, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.13</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Increase in net tangible book value per share attributable to this offering</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">As adjusted net tangible book value per share as of March&nbsp;31, 2014 after giving effect to this offering</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Dilution in net tangible book value per share to new investors</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The above table is based on 25,090,386 shares
of our common stock outstanding as of March 31, 2014 and excludes, as of that date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>2,497,911 shares of common stock issuable upon the exercise of stock options outstanding prior to this offering under our stock
option plans and stock incentive plans, at a weighted average exercise price of $1.33 per share;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>2,521,733 shares of common stock available for future grants under our stock option plans and stock incentive plans; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>1,242,250shares of common stock issuable upon the exercise of warrants outstanding prior to this offering, at a weighted average
exercise price of $2.53 per share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To the extent that any options or warrants
are exercised, new options are issued under our stock option or stock incentive plans, or we otherwise issue additional shares
of common stock in the future, there will be further dilution to new investors. In addition, we may choose to raise additional
capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future
operating plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the
issuance of these securities could result in further dilution to our stockholders.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="hti_007"></A>DESCRIPTION
OF THE SECURITIES WE ARE OFFERING</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In this offering, we are offering up to
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The material terms and provisions of our
common stock and each other class of our securities which qualifies or limit our common stock are described under the caption &ldquo;Description
of Capital Stock&rdquo; starting on page 5 of the accompanying prospectus.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="hti_008"></A>UNDERWRITING</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The underwriters named below, for which
William Blair &amp; Company, L.L.C. is acting as representative, have severally agreed, subject to the terms and conditions set
forth in the underwriting agreement by and among the underwriters and us, to purchase from us, the respective number of shares
of common stock set forth opposite each underwriters&rsquo; name in the table below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid">Underwriter</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt; border-bottom: Black 1pt solid">Number of<BR> Shares</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 87%; text-align: left; text-indent: -12pt; padding-left: 12pt">William Blair &amp; Company, L.L.C.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"></TD><TD STYLE="width: 10%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -12pt; padding-left: 12pt">Craig-Hallum Capital Group LLC</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -12pt; padding-left: 12pt">Roth Capital Partners, LLC</TD><TD STYLE="font-size: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 1pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -12pt; padding-left: 0.5in">Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The underwriters are committed to take
and pay for all of the shares being offered, if any are taken, other than the shares covered by the option described below unless
and until this option is exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">If the underwriters sell more shares than
the total number set forth in the table above, the underwriters have an option to buy up to an additional &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
shares from us on the same terms and conditions solely to cover over-allotments, if any. The underwriters can exercise this option
at any time within 30 days after the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The following table shows the per share
and total public offering price, underwriting discounts and commissions and proceeds, before expenses, to us. Such amounts are
shown assuming both no exercise and full exercise of the underwriters&rsquo; over-allotment option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Per<BR> Share</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">No<BR> Exercise</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Full<BR> Exercise</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 61%; text-indent: -12pt; padding-left: 12pt">Public offering price</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -12pt; padding-left: 12pt">Underwriting discounts and commissions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -12pt; padding-left: 12pt">Proceeds, before expenses, to us</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Shares sold by the underwriters to the
public will initially be offered at the public offering price set forth on the cover of this prospectus. The underwriters propose
to offer the shares of common stock initially at the public offering price on the cover page of this prospectus and to selling
group members at that price less a selling concession of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. After
the offering, the underwriters may reduce the initial public offering price and concession to dealers. No such reduction will change
the amount of proceeds received by us as set forth on the cover page. The offering of the shares by the underwriters is subject
to receipt and acceptance and subject to the underwriters&rsquo; right to reject any order in whole or in part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">We and each of our executive officers and
directors have agreed with the underwriters, subject to certain exceptions, not to (i) offer, pledge, sell, contract to sell, sell
any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant for the sale of,
or otherwise dispose of or transfer any shares of common stock or any securities convertible into or exchangeable or exercisable
for shares of common stock, whether now owned or subsequently acquired or with respect to which we have acquired the power of disposition,
or (ii) cause to be filed, any registration statement under the Securities Act with respect to any of the foregoing or (iii) enter
into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic
consequence of ownership of the common stock, whether any such swap or transaction is to be settled by delivery of common stock
or other securities, in cash or otherwise, during the period from the date of this prospectus supplement continuing through the
date 90 days after the date of this prospectus supplement, except with the prior written consent of William Blair &amp; Company,
L.L.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The 90-day restricted period described
in the preceding paragraph may be extended if: (1) during the last 17 days of the 90-day restricted period, (a) we release earnings
results, (b) announce material news or (c) a material event relating to our business occurs or (2) before the expiration of the
90-day restricted period, we announce that we will release earnings results or become aware that material news or a material event
will occur during the 16-day period following the last day of the 90-day restricted period, then in each case the 90-day restricted
period may be extended by the underwriters by written notice to us, and the restrictions imposed shall continue to apply, until
the expiration of the 18-day period beginning on the date of the earnings release or the announcement of material news or the occurrence
of a material event relating to our business, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Our common stock is listed on the NASDAQ
Capital Market under the symbol &ldquo;HDSN.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In connection with the offering, the underwriters
may purchase and sell shares of common stock in the open market. These transactions may include short sales, stabilizing transactions
and purchases to cover positions created by short sales. Shorts sales involve the sale by the underwriters of a greater number
of shares than they are required to purchase in the offering. &ldquo;Covered&rdquo; short sales are sales made in an amount not
greater than the underwriters&rsquo; option to purchase additional shares from us in the offering. The underwriters may close out
any covered short position by either exercising their option to purchase additional shares or purchasing shares in the open market.
In determining the source of shares to close out the covered short position, the underwriters will consider, among other things,
the price of shares available for purchase in the open market as compared to the price at which they may purchase additional shares
pursuant to the option granted to them by us. &ldquo;Naked&rdquo; short sales are any sales in excess of such option. The underwriters
must close out any naked short position by purchasing shares in the open market. A naked short position is more likely to be created
if the underwriters are concerned that there may be downward pressure on the price of the common stock in the open market after
pricing that could adversely affect investors who purchase in the offering. Stabilizing transactions consist of various bids for
or purchases of common stock made by the underwriters in the open market prior to the completion of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The underwriters may also impose a penalty
bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it
because the representatives have repurchased shares sold by or for the account of such underwriter in stabilizing or short covering
transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">Purchases to cover a short position and
stabilizing transactions, as well as other purchases by the underwriters for their own account, may have the effect of preventing
or retarding a decline in the market price of the Company&rsquo;s stock, and together with the imposition of the penalty bid, may
stabilize, maintain or otherwise affect the market price of the common stock. As a result, the price of the common stock may be
higher than the price that otherwise might exist in the open market. If these activities are commenced, they may be discontinued
at any time. These transactions may be effected on the NASDAQ Capital Market, in the over-the-counter market or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">We estimate that our offering expenses
will be approximately $&#9; , including up to $150,000 that we have agreed to reimuburse to the underwriters for reasonably documented,
actual out-of-pocket expenses reasonably incurred by the underwriters, including reasonable fees and expenses of its counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">We have agreed to indemnify the underwriters
against certain liabilities, including liabilities under the Securities Act. If we are unable to provide this indemnification,
we have agreed to contribute to payments the underwriters may be required to make in respect of those liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Relationships</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">The underwriters and their respective affiliates
are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment
banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage
activities. The underwriters and their respective affiliates have, from time to time, performed, and may in the future perform,
various financial advisory and investment banking services for us, for which they received or will receive customary fees and expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In the ordinary course of their various
business activities, the underwriters and their respective affiliates may make or hold a broad array of investments and actively
trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their
own account and for the accounts of their customers, and such investment and securities activities may involve securities and/or
instruments of ours. The underwriters and their respective affiliates may also make investment recommendations and/or publish or
express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients
that they acquire, long and/or short positions in such securities and instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">William Blair &amp; Company, L.L.C., an
underwriter of this offering, beneficially owns approximately 9.94% of the outstanding shares of our common stock (as determined
under Section 13(d) of the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Notice to Non-U.S. Investors </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In relation to each member state of the
European Economic Area that has implemented the Prospectus Directive, each of which we refer to as a relevant member state, with
effect from and including the date on which the Prospectus Directive is implemented in that relevant member state, or the relevant
implementation date, an offer of securities described in this prospectus supplement may not be made to the public in that relevant
member state other than:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24.5pt"></TD><TD STYLE="width: 18pt">&bull;</TD><TD>To legal entities that are authorized or regulated to operate in the financial markets or, if not so authorized or regulated,
whose corporate purpose is solely to invest in securities;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24.5pt"></TD><TD STYLE="width: 18pt">&bull;</TD><TD>To any legal entity that has two or more of (i) an average of at least 250 employees during the last financial year; (ii) a
total balance sheet of more than &euro;43,000,000 and (iii) an annual net turnover of more than &euro;50,000,000, as shown in its
last annual or consolidated accounts;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24.5pt"></TD><TD STYLE="width: 18pt">&bull;</TD><TD>To fewer than 100 natural or legal persons (other than qualified investors as defined in the Prospectus Directive) subject
to obtaining the prior consent of representatives for any such offer; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24.5pt"></TD><TD STYLE="width: 18pt">&bull;</TD><TD>In any other circumstances that do not require the publication of a prospectus pursuant to Article 3 of the Prospectus Directive;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">provided that no such offer of securities shall require us or
the underwriters to publish a prospectus pursuant to Article 3 of the Prospectus Directive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">For the purposes of this provision, the
expression an &ldquo;offer of shares to the public&rdquo; in relation to any shares of common stock in any relevant member state
means the communication in any form and by any means of sufficient information on the terms of the offer and the shares to be offered
so as to enable an investor to decide to purchase or subscribe for the shares, as the same may be varied in that member state by
any measure implementing the Prospectus Directive in that member state and the expression &ldquo;Prospectus Directive&rdquo; means
Directive 2003/71/EC and includes any relevant implementing measure in each relevant member state.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><B>Investors considering the purchase of
our common stock should consult their own tax advisors regarding the application of the U.S. federal income and estate tax laws
to their particular situations and the consequences of foreign, state or local laws, and tax treaties.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="hti_009"></A>LEGAL MATTERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain legal matters relating to the validity
of the securities offered hereby will be passed upon for us by Blank Rome LLP, New York, New York. Goodwin Procter LLP, New York,
New York is counsel for the underwriters in connection with this offering.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="hti_010"></A>EXPERTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The financial statements as of December
31, 2013 and 2012&nbsp;&nbsp;and for the years then ended incorporated by reference in this prospectus supplement have been so
incorporated in reliance on the report of BDO USA, LLP, an independent registered public accounting firm, incorporated herein by
reference, given on the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="hti_011"></A>WHERE YOU
CAN FIND MORE INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are subject to the informational requirements
of the Exchange Act and, therefore, we file annual, quarterly and current reports, proxy statements and other information with
the SEC. Our SEC filings are available to the public over the Internet at the SEC&rsquo;s website at <I>www.sec.gov</I>.&nbsp;&nbsp;The
SEC&rsquo;s website contains reports, proxy and information statements and other information regarding issuers, such as us, that
file electronically with the SEC.&nbsp;&nbsp;You may also read and copy any document we vile with the SEC at the SEC&rsquo;s public
Reference Room at 100 F Street, N.E., Room 1580, Washington, D.C. 20549.&nbsp;&nbsp;You may also obtain copies of these documents
at prescribed rates by writing to the SEC.&nbsp;&nbsp;Please call the SEC at 1-800-SEC-0330 for further information on the operation
of its Public Reference Room.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus supplement constitutes a
part of a registration statement on Form S-3 that we have filed with the SEC under the Securities Act. This prospectus supplement
does not contain all of the information set forth in the registration statement, certain parts of which are omitted in accordance
with the rules and regulations of the SEC. For further information about us and our securities we refer you to the registration
statement and the accompanying exhibits and schedules. The registration statement may be inspected at the Public Reference Room
maintained by the SEC at the address set forth above. Statements contained in this prospectus supplement regarding the contents
of any contract or any other document filed as an exhibit are not necessarily complete. In each instance, reference is made to
the copy of such contract or document filed as an exhibit to the registration statement, and each statement is qualified in all
respects by that reference</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="hti_012"></A>INFORMATION
INCORPORATED BY REFERENCE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The SEC allows us to incorporate by reference
into this prospectus supplement certain information we file with it, which means we can disclose important information to you by
referring you to documents we have filed with the SEC. The information we incorporate by reference into this prospectus supplement
is legally deemed to be a part of this prospectus supplement, except for any information superseded by other information contained
in, or incorporated by reference into, this prospectus supplement.&nbsp;&nbsp;Our file number for filings we make with the SEC
under the Exchange Act is 001-13412.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any statement contained in this prospectus
supplement or in a document incorporated or deemed to be incorporated by reference in this prospectus supplement is deemed to be
modified or superseded to the extent that a statement contained in this prospectus supplement, or in any other document we subsequently
file with the SEC, modifies or supersedes that statement.&nbsp;&nbsp;If any statement is modified or superseded, it does not constitute
a part of this prospectus supplement and the accompanying prospectus, except as modified or superseded.&nbsp;&nbsp;Information
that is &ldquo;furnished to&rdquo; the SEC shall not be deemed &ldquo;filed with&rdquo; the SEC and shall not be deemed incorporated
by reference into this prospectus supplement or the accompanying prospectus is a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus supplement incorporates
by reference the following reports and statements filed by us with the SEC:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Our Annual Report on Form 10-K for the fiscal year ended December 31, 2013, filed with the SEC on February 28, 2014;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>The description of&nbsp;our common stock contained in our Registration Statement on Form 8-A together with any amendments thereto;
</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Our Quarterly Report on Form 10-Q for the quarter ended March&nbsp;31, 2014, filed with the SEC on April 29, 2014; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Our Current Report on Form 8-K, as filed with the SEC on June&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2014.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are also incorporating by reference any
future filings we make with the SEC under Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus
supplement and the accompanying prospectus and prior to the termination of this offering, except for information furnished under
Item&nbsp;2.02 or Item&nbsp;7.01 of our Current Reports on Form 8-K which is not deemed to be filed and not incorporated by reference
herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will furnish without charge to you, on
written or oral request, a copy of any or all of the documents incorporated by reference, including exhibits to these documents.
You should direct any requests for documents to Hudson Technologies, Inc., Attention: Stephen Mandracchia, One Blue Hill Plaza,
Pearl River, New York 10965, telephone: (845)&nbsp;735-6000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Filed Pursuant to Rule 424(b)(3)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Registration No. 333-185490</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>HUDSON
TECHNOLOGIES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>$50,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Debt Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>600,000 Shares of Common Stock Offered</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>by the Selling Shareholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">From time to time, we may offer and sell
common stock, preferred stock, warrants or debt securities and/or any combination of securities described in this prospectus, either
individually or in units, at prices and on terms described in one or more supplements to this prospectus. The aggregate public
offering price of the securities offered by us under this prospectus, sometimes referred to as the &ldquo;shelf securities,&rdquo;
will not exceed $50,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, the selling shareholders set
forth in this prospectus under the heading &ldquo;Selling Shareholders&rdquo; beginning on page 4 of this prospectus may, from
time to time, use this prospectus to sell in one or more offerings an aggregate of up to 600,000 shares of our common stock, sometimes
referred to as &ldquo;resale shares,&rdquo; in the amounts and at the times determined solely by the selling shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus provides you with a general
description of the securities that we and the selling shareholders may offer in one or more offerings. Each time we offer securities,
we will provide a supplement to this prospectus that will contain more specific information about the terms of that offering. We
may also add, update or change in a prospectus supplement any of the information contained in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>You should read both this prospectus
and the applicable prospectus supplement, as well as any documents incorporated by reference in this prospectus and/or the applicable
prospectus supplement, before you make your investment decision.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our common stock is traded on the Nasdaq
Capital Market under the trading symbol &ldquo;HDSN.&rdquo; On January 17, 2013, the last reported sale price of our common stock
on the Nasdaq Capital Market was $3.77 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Investing in our securities involves
risks. See the risks and uncertainties described under the heading &ldquo;Risk Factors&rdquo; beginning on page 2 of this prospectus,
in any applicable prospectus supplement and under similar headings in the other documents that are incorporated by reference into
this prospectus.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>This prospectus may not be used by us
to sell any securities unless accompanied by a prospectus supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The securities offered by this prospectus
may be sold directly to investors, through agents designated from time to time or to or through one or more underwriters or dealers
or in other manners as set forth under the heading &ldquo;Plan of Distribution.&rdquo; Each time we offer shelf securities in a
primary offering, or any selling shareholder offers resale shares in a manner other than as set forth in the Plan of Distribution,
a supplement to this prospectus applicable to such offering will provide the specific terms of the plan of distribution for such
offering and the net proceeds that we expect to receive from any such primary offering. We will not receive any proceeds from the
sale of the resale shares covered by this prospectus. We are bearing all of the expenses in connection with this registration statement,
but all selling and other expenses incurred by the selling shareholders, including commissions and discounts, if any, attributable
to the sale or disposition of the resale shares, will be borne by them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of January&nbsp;17, 2013, the aggregate
market value of our outstanding common stock held by non-affiliates was approximately $72,363,641, which was calculated based on
17,437,022 shares of outstanding common stock held by non-affiliates as of such date at a price per share of $4.15, the closing
sale price of our common stock on January 10, 2013. We have not sold any securities pursuant to General Instruction&nbsp;I.B.6
of Form&nbsp;S-3 during the 12 calendar months prior to, and including, the date of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful
or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is January 22,
2013.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 92%"><A HREF="#hti_013">ABOUT THIS PROSPECTUS</A></td>
    <TD STYLE="width: 8%; text-align: right">1</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#hti_014">ABOUT HUDSON TECHNOLOGIES, INC.</A></td>
    <TD STYLE="text-align: right">1</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#hti_015">RISK FACTORS</A></td>
    <TD STYLE="text-align: right">2</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#hti_016">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></td>
    <TD STYLE="text-align: right">3</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#hti_017">USE OF PROCEEDS</A></td>
    <TD STYLE="text-align: right">3</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#hti_018">SELLING SHAREHOLDERS</A></td>
    <TD STYLE="text-align: right">4</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#hti_019">DESCRIPTION OF CAPITAL STOCK</A></td>
    <TD STYLE="text-align: right">5</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#hti_020">DESCRIPTION OF WARRANTS</A></td>
    <TD STYLE="text-align: right">8</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#hti_021">DESCRIPTION OF DEBT SECURITIES</A></td>
    <TD STYLE="text-align: right">10</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#hti_022">DESCRIPTION OF UNITS</A></td>
    <TD STYLE="text-align: right">16</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#hti_023">PLAN OF DISTRIBUTION</A></td>
    <TD STYLE="text-align: right">17</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#hti_024">LEGAL MATTERS</A></td>
    <TD STYLE="text-align: right">19</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#hti_025">EXPERTS</A></td>
    <TD STYLE="text-align: right">19</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#hti_026">WHERE YOU CAN FIND MORE INFORMATION</A></td>
    <TD STYLE="text-align: right">19</td></tr>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</td>
    <TD STYLE="text-align: right">&nbsp;</td></tr>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#hti_027">INFORMATION INCORPORATED BY REFERENCE</A></td>
    <TD STYLE="text-align: right">20</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="hti_013"></A>ABOUT
THIS PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information contained in this prospectus
is not complete and may be changed. You should rely only on the information provided in or incorporated by reference in this prospectus,
any prospectus supplement or documents to which we otherwise refer you. We and the selling shareholders have not authorized anyone
else to provide you with different information. We and the selling shareholders are not making an offer of any securities in any
jurisdiction where the offer is not permitted, and this document may only be used where it is legal to sell the securities described
herein. You should not assume that the information in this prospectus, any prospectus supplement or any document incorporated by
reference is accurate as of any date other than the date of the document in which such information is contained or such other date
referred to in such document, regardless of the time of any sale or issuance of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus is part of a registration
statement that we filed with the Securities and Exchange Commission, or SEC, to register an indeterminable number of shares of
common stock, preferred stock, warrants and debt securities as may from time to time be offered for sale by us, either individually
or in units, at indeterminate prices (up to an aggregate maximum offering price for all such securities of $50,000,000), and up
to 600,000 shares of common stock by the selling shareholders, using a &ldquo;shelf&rdquo; registration process. By using a shelf
registration statement, we and the selling shareholders may offer and sell from time to time in one or more offerings the securities
described in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus provides you with some of
the general terms that may apply to an offering of our securities. Each time we sell securities under this shelf registration we
will provide a prospectus supplement that will contain specific information about the terms of that specific offering, including
the number and price per security (or exercise price) of the securities to be offered and sold in that offering and the specific
manner in which such securities may be offered. We may also provide a prospectus supplement to the extent any selling shareholder
offers resale shares in a manner other than as set forth in the Plan of Distribution in order to provide the specific terms of
the plan of distribution for such offering. A prospectus supplement may also add to, update or change any of the information contained
in this prospectus. If there is an inconsistency between the information in this prospectus and a prospectus supplement, you should
rely on the information in the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should read carefully both this prospectus
and the applicable prospectus supplement, together with the additional information incorporated by reference herein as described
under the heading &ldquo;Information Incorporated by Reference,&rdquo; before making an investment decision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The registration statement that contains
this prospectus (including the exhibits to the registration statement) contains additional information about us and the securities
offered under this prospectus. The registration statement can be read at the SEC web site (<I> www.sec.gov)</I> or at the SEC offices
mentioned under the heading &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="hti_014"></A>ABOUT
HUDSON TECHNOLOGIES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are a refrigerant services company providing
innovative solutions to recurring problems within the refrigeration industry. Our products and services are primarily used in commercial
air conditioning, industrial processing and refrigeration systems, including (i) refrigerant sales, (ii) refrigerant management
services consisting primarily of reclamation of refrigerants and (iii) RefrigerantSide&reg; Services performed at a customer's
site, consisting of system decontamination to remove moisture, oils and other contaminants. In addition, RefrigerantSide&reg; Services
include predictive and diagnostic services for industrial and commercial refrigeration applications designed to predict potential
catastrophic problems and identify inefficiencies in an operating system. Our Chiller Chemistry&reg;, Chill Smart&reg;, Fluid Chemistry,
and Performance Optimization are predictive and diagnostic service offerings. As a component of our products and services, we also
participate in the generation of carbon offset projects. We operate principally through our wholly-owned subsidiary, Hudson Technologies
Company. Unless the context requires otherwise, references to the &quot;Company&quot;, &quot;Hudson&quot;, &quot;we&quot;, &quot;us&quot;,
&quot;our&quot;, or similar pronouns refer to Hudson Technologies, Inc. and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We were incorporated under the laws of the
State of New York. Our executive offices are located at One Blue Hill Plaza, Pearl River, New York and our telephone number is
(845) 735-6000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="hti_015"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any investment in our securities involves
a high degree of risk. You should consider carefully the risk factors described in our periodic reports filed with the SEC, including
the risks, uncertainties and assumptions discussed under the heading &ldquo;Risk Factors&rdquo; included in our most recent annual
report on Form 10-K, as such may be revised or supplemented prior to the completion of this offering by more recently filed quarterly
reports on Form 10-Q, each of which is or upon filing will be incorporated herein by reference, and which may be amended, supplemented
or superseded from time to time by other reports we file with the SEC in the future, and those identified in any applicable prospectus
supplement, as well as other information in this prospectus and any applicable prospectus supplement and the documents incorporated
by reference herein before purchasing any of our securities. Each of these risk factors could adversely affect our business, operating
results and financial condition, as well as adversely affect the value of an investment in our securities. Additional risks and
uncertainties not presently known to us or that we currently deem immaterial may also impair our business, operating results, prospects
or financial condition. The additional risks discussed below also include forward-looking statements and our actual results may
differ substantially from those discussed in these forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>We may need additional financing to
satisfy our future capital requirements, which may not be readily available to us.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our capital requirements have been and may
be significant in the future. In the future, we may incur additional expenses in the development and implementation of our operations.
Due to fluctuations in the price, demand and availability of new refrigerants, our existing credit facility that expires in June
2015 may not in the future be sufficient to provide all of the capital that we need to acquire and manage our inventories of new
refrigerant. As a result, we may be required to seek additional equity or debt financing in order to develop our RefrigerantSide&reg;
Services business, our refrigerant sales business and our other businesses. We have no current arrangements with respect to, or
sources of, additional financing other than our existing credit facility. There can be no assurance that we will be able to renew
this credit facility or obtain any additional financing on terms acceptable to us or at all. Our inability to obtain financing,
if and when needed, could materially adversely affect our business and future financial condition and could require us to curtail
or otherwise cease our existing operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>We will have broad discretion over
the use of the proceeds to us from any primary offering and may apply the proceeds to uses that do not improve our operating results
or the value of your securities.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will have broad discretion to use the
net proceeds to us from a primary offering, if any, and investors will be relying solely on the judgment of our board of directors
and management regarding the application of these proceeds. Although we expect to use the net proceeds from a primary offering
for general corporate purposes, including without limitation additions to our working capital, capital expenditures and potential
acquisitions of, or investments in, companies and technologies that complement our businesses, we have not allocated these net
proceeds for specific purposes. Investors will not have the opportunity, as part of their investment decision, to assess whether
the proceeds are being used appropriately. Our use of any such proceeds may not improve our operating results or increase the value
of the securities being offered hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Future sales of shares of our common
stock may cause the prevailing market price of our shares to decrease and could harm our ability to raise additional capital.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have previously issued a substantial
number of shares of common stock, which are eligible for resale under Rule 144 of the Securities Act of 1933, or Securities Act,
and may become freely tradable. We have also registered shares that are issuable upon the exercise of warrants and options. If
holders of warrants and options choose to exercise their purchase rights and sell shares of common stock in the public market,
or if holders of currently restricted common stock choose to sell such shares of common stock in the public market under Rule 144
or otherwise, or attempt to publicly sell such shares all at once or in a short time period, the prevailing market price for our
common stock may decline. The sale of shares of common stock issued upon the exercise of our securities could also dilute the holdings
of our existing shareholders. The market price of our common stock could drop due to sales of a large number of shares or the perception
that such sales could occur. These factors also could make it more difficult to raise funds through future offerings of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="hti_016"></A>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus and the documents incorporated
by reference herein contain statements that we believe are &ldquo;forward-looking statements&rdquo; as that term is used in the
Private Securities Litigation Reform Act of 1995 and are intended to enjoy protection of the safe harbor for forward-looking statements
provided by that Act. These forward-looking statements are based on our current expectations, assumptions, estimates and projections
about our business and our industry. Forward-looking statements include statements regarding our future financial position, performance
and achievements, business strategy, and plans and objectives of management for future operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In some cases, you can identify forward-looking
statements by terms such as &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;will,&rdquo; &ldquo;could,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;project,&rdquo; &ldquo;predict,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo;
&ldquo;plan,&rdquo; &ldquo;seek,&rdquo; &ldquo;expect,&rdquo; &ldquo;future&rdquo; and &ldquo;intend&rdquo; or the negative of
these terms or other comparable expressions which are intended to identify forward-looking statements. These statements are only
predictions and are not guarantees of future performance. They are subject to known and unknown risks, uncertainties and other
factors, some of which are beyond our control and difficult to predict and could cause our actual results to differ materially
from those expressed or forecasted in, or implied by, the forward-looking statements. In evaluating these forward-looking statements,
you should carefully consider the risks and uncertainties referred to under the caption &ldquo;Risk Factors&rdquo; above and elsewhere
in this prospectus, including those described in documents incorporated by reference herein, and those described in any applicable
prospectus supplement. Given these uncertainties, you should not place undue reliance on these forward-looking statements. In addition,
these forward-looking statements reflect our view only as of the date they are made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as required by law, we assume no
obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially
from those anticipated in these forward-looking statements, even if new information becomes available in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All forward-looking statements attributable
to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="hti_017"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as described in any prospectus supplement,
we currently intend to use the net proceeds from the sale of shelf securities under this prospectus for general corporate purposes,
including without limitation additions to our working capital, capital expenditures and, although we have no present understandings,
commitments or agreements to do so, potential acquisitions of, or investments in, companies and technologies that complement our
businesses. The prospectus supplement with respect to an offering of the shelf securities may identify different or additional
uses for the proceeds of that offering. Pending any such uses, we may temporarily invest the net proceeds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will not receive any of the proceeds
from the sale of resale shares offered by the selling shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="hti_018"></A>SELLING
SHAREHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The resale shares offered under this prospectus
may be sold from time to time for the account of the selling shareholders named in the following table. The table also contains
information, to our knowledge, regarding each selling shareholder&rsquo;s beneficial ownership of shares of our common stock as
of January 17, 2013, and as adjusted to give effect to the assumed sale of all of the resale shares registered hereby. As of January
17, 2013, we had 24,146,008 shares of common stock outstanding. A person is deemed to be the beneficial owner of securities that
can be acquired by such person within 60 days from January 17, 2013. Accordingly, each beneficial owner's percentage ownership
is determined by assuming that options and warrants that are held by such person (but not held by any other person) and which are
exercisable within 60 days from January 17, 2013 have been exercised. Except as otherwise indicated, each person shown in the table
has sole voting and investment power with respect to the shares of common stock listed next to his name. The address for each selling
shareholder, unless otherwise noted, is c/o Hudson Technologies, Inc. at PO Box 1541, One Blue Hill Plaza, Pearl River, New York
10965.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><B>&nbsp;</B></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="6" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Beneficial Ownership
    of <BR>Shares of Common Stock</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><B>&nbsp;</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP><B>&nbsp;</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="6" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><B>Shares Beneficially Owned <BR>Assuming
    Sale of Shares<BR>
    Registered</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid"><B>Name of Shareholder</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><B>Number of <BR>Shares</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Percentage</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><B>&nbsp;</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><B>Number of <BR>Shares<BR> Registered for<BR>
    Resale*</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid"><B>Number of <BR>Shares</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Percentage</B></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; text-align: left">Kevin J. Zugibe</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">5,007,555</TD><TD STYLE="width: 1%; text-align: left">(1)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">19.99</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">250,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">4,757,555</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">18.99</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Brian F. Coleman</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">947,176</TD><TD STYLE="text-align: left">(2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.83</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">847,176</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.42</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">James R. Buscemi</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">535,055</TD><TD STYLE="text-align: left">(3)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.19</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">435,055</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.78</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stephen P. Mandracchia</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,220,195</TD><TD STYLE="text-align: left">(4)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.05</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">150,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,070,195</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.44</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,709,981</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33.10</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">600,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,109,981</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30.82</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* The shares registered for resale were among the shares of
common stock purchased by the selling shareholders from Fleming US Discovery Fund III, L.P. for a purchase price of $0.65 per share
on June 28, 2007 in private transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1) Includes (i) 87,500 shares which may be purchased at $1.13
per share; (ii) 193,750 shares which may be purchased at $1.15 per share; (iii) 37,500 shares which may be purchased at $.83 per
share; (iv) 18,750 shares which may be purchased at $.95 per share; (v) 93,750 shares which may be purchased at $1.02 per share;
(vi) 18,750 shares which may be purchased at $.87 per share; (vii) 18,750 shares which may be purchased at $2.15 per share; (viii)
123,750 shares which may be purchased at $1.76 per share; (ix) 35,000 shares which may be purchased at $1.40 per share; (x) 9,300
shares which may be purchased at $1.02 per share; (xi) 195,000 shares that may be purchased at $0.85 per share; and (xii) 78,000
shares which may be purchased at $1.26 per share, under immediately exercisable options. Mr. Zugibe is a Director, Chairman and
Chief Executive Officer of Hudson.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(2) Includes (i) 75,000 shares which may be purchased at $1.13
per share; (ii) 18,750 shares which may be purchased at $1.15 per share; (iii) 25,000 shares which may be purchased at $.83 per
share; (iv) 12,500 shares which may be purchased at $.95 per share; (v) 62,500 shares which may be purchased at $1.02 per share;
(vi) 12,500 shares which may be purchased at $.87 per share; (vii) 12,500 shares which may be purchased at $2.15 per share; (viii)
82,500 shares which may be purchased at $1.76 per share; (ix) 32,500 shares which may be purchased at $1.40 per share; (x) 8,100
shares which may be purchased at $1.02 per share, (xi) 180,000 shares which may be purchased at $0.85 per share; and (xii) 75,000
shares which may be purchased at $1.26 per share, under immediately exercisable options. Mr. Coleman is a Director, President and
Chief Operating Officer of Hudson.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(3) Includes (i) 6,250 shares which may be purchased at $1.13
per share; (ii) 9,375 shares which may be purchased at $1.15 per share; (iii) 8,595 shares which may be purchased at $.83 per share;
(iv) 6,125 shares which may be purchased at $.95 per share; (v) 31,250 shares which may be purchased at $1.02 per share; (vi) 6,250
shares which may be purchased at $.87 per share; (vii) 6,250 shares which may be purchased at $2.15 per share; (viii) 41,250 shares
which may be purchased at $1.76 per share; (ix) 16,625 shares which may be purchased at $1.40 per share; (x) 6,500 shares which
may be purchased at $1.02 per share; (xi) 100,000 shares that may be purchased at $0.85 per share; and (xii) 48,000 shares which
may be purchased at $1.26 per share, under immediately exercisable options. Mr. Buscemi is Chief Financial Officer of Hudson.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(4) Includes (i) 1,402,920 shares held of record in the name
of Mr. Mandracchia&rsquo;s wife, Theresa Mandracchia, over which Mr. Mandracchia has sole voting power and shared dispositive power;
and (ii) the following shares which may be purchased by Mr. Mandracchia upon the exercise of options previously granted to him:
(a) 40,000 shares which may be purchased at $1.13 per share; (b) 9,375 shares which may be purchased at $1.15 per share; (c) 12,500
shares which may be purchased at $.83 per share; (d) 6,250 shares which may be purchased at $.95 per share; (e) 31,250 shares which
may be purchased at $1.02 per share; (f) 6,250 shares which may be purchased at $.87 per share; (g) 6,250 shares which may be purchased
at $2.15 per share; (h) 51,250 shares which may be purchased at $1.76 per share; (i) 20,750 shares which may be purchased at $1.40
per share; (j) 7,400 shares which may be purchased at $1.02 per share; (k) 125,000 shares that may be purchased at $0.85 per share;
and (l) 58,000 shares which may be purchased at $1.26 per share, under immediately exercisable options. Mr. Mandracchia is Vice
President Legal and Regulatory, and Secretary, of Hudson.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Options: NewSection; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="hti_019"></A>DESCRIPTION
OF CAPITAL STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following description summarizes the
material terms of our capital stock. Because it is only a summary, it does not contain all the information that may be important
to you. For a complete description, you should refer to the applicable prospectus supplement, our certificate of incorporation,
as amended, and amended and restated by-laws and to the applicable provisions of New York law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of the date of this prospectus, Hudson
is authorized to issue 50,000,000 shares of common stock. As of January 17, 2013, there were 24,146,008 shares of common stock
outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The holders of common stock are entitled
to one vote for each share held of record on all matters to be voted on by shareholders. There is no cumulative voting with respect
to the election of directors, with the result that the holders of more than 50% of the shares voting for the election of directors
can elect all of the directors then up for election. The holders of common stock are entitled to receive dividends when, as and
if declared by our board of directors out of funds legally available therefor. In the event of liquidation, dissolution or winding
up of Hudson, the holders of common stock are entitled to share in all assets remaining which are available for distribution to
them after payment of liabilities and after provision has been made for each class of stock, if any, having preference over the
common stock. Holders of shares of common stock have no conversion, preemptive or other subscription rights, and there are no redemption
provisions applicable to the common stock. All of the outstanding shares of common stock are fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our common stock is listed on the Nasdaq
Capital Market under the symbol &ldquo;HDSN.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Transfer Agent</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The transfer agent and registrar for the
common stock is Continental Stock Transfer &amp; Trust Company, New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Preferred Stock&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of the date of this prospectus, Hudson
is authorized to issue 5,000,000 shares of&nbsp;preferred stock. As of January 17, 2013, there were 150,000 shares of preferred
stock designated as Series A Convertible Preferred Stock and no shares of preferred stock outstanding. Hudson has no intent to
issue any shares of its Series A Convertible Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This section describes the general terms
of our preferred stock to which any prospectus supplement may relate. A prospectus supplement will describe the terms relating
to any preferred stock to be offered by us in greater detail, and may provide information that is different from this prospectus.
If the information in the prospectus supplement with respect to the particular preferred stock being offered differs from this
prospectus, you should rely on the information in the prospectus supplement. A copy of our certificate of incorporation, as amended,
has been incorporated by reference from our filings with the SEC as an exhibit to the registration statement of which this prospectus
is a part. A certificate of amendment to our certificate of incorporation will specify the terms of any preferred stock being offered,
and will be filed or incorporated by reference from a report that we file with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under our certificate of incorporation,
as amended, we have the authority to issue 5,000,000 shares of preferred stock. The authorized preferred stock can be issued from
time to time in one or more series. Our board of directors has the power, without shareholder approval, to issue shares of one
or more series of preferred stock, at any time, for such consideration and with such relative rights, privileges, preferences and
other terms as the board may determine, including terms relating to dividend rates, redemption rates, liquidation preferences and
voting, sinking fund and conversion or other rights. The rights and terms relating to any new series of preferred stock could adversely
affect the voting power or other rights of the holders of the common stock or could be utilized, under certain circumstances, as
a method of discouraging, delaying or preventing a change in control of Hudson.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following description of our preferred
stock, and any description of our preferred stock in a prospectus supplement, may not be complete and is subject to, and qualified
in its entirety by reference to, New York law and the actual terms and provisions contained in our certificate of incorporation
and bylaws, each as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Terms&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our board of directors will fix the rights,
preferences, privileges, qualifications and restrictions of the preferred stock of each series that we sell under this prospectus
and applicable prospectus supplements in the amendment to our certificate of incorporation relating to that series.&nbsp; We will
incorporate by reference into the registration statement, of which this prospectus is a part, the form of any amendment to our
certificate of incorporation that describes the terms of the series of preferred stock we are offering before the issuance of the
related series of preferred stock.&nbsp; This description of the preferred stock in the amendment to our certificate of&nbsp;incorporation
and any applicable prospectus supplement may include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the number of shares of preferred stock to be issued
and the offering price of the preferred stock;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the title and stated value of the preferred stock;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">dividend rights, including dividend rates, periods,
or payment dates, or methods of calculation of dividends applicable to the preferred stock;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">whether dividends will be cumulative or non-cumulative,
and if cumulative the date from which distributions on the preferred stock shall accumulate;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the right to convert the preferred stock into a different
type of security;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">voting rights, if any, attributable to the preferred
stock;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">rights and preferences upon our liquidation or winding
up of our affairs;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">terms of redemption;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">preemption rights, if any;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the procedures for any auction and remarketing, if
any, for the preferred stock;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the provisions for a sinking fund, if any, for the
preferred stock;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any listing of the preferred stock on any securities
exchange;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the terms and conditions, if applicable, upon which
the preferred stock will be convertible into our common stock, including the conversion price (or manner of calculation thereof);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">a discussion of federal income tax considerations applicable
to the preferred stock, if material;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the relative ranking and preferences of the preferred
stock as to dividend or other distribution rights and rights if we liquidate, dissolve or wind up our affairs;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any limitations on issuance of any series of preferred
stock ranking senior to or on a parity with the series of preferred stock being offered as to distribution rights and rights upon
the liquidation, dissolution or winding up or our affairs;&nbsp;and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any other specific terms, preferences, rights, limitations
or restrictions of the preferred stock.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Rank&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless otherwise indicated in the applicable
supplement to this prospectus, shares of our preferred stock will rank, with respect to payment of distributions and rights upon
our liquidation, dissolution or winding up, and allocation of our earnings and losses:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">senior to all classes or series of our common stock,
and to all of our equity securities ranking junior to the preferred stock;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">on a parity with all equity securities issued by us,
the terms of which specifically provide that these equity securities rank on a parity with the preferred stock;&nbsp;and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">junior to all equity securities issued by us, the terms
of which specifically provide that these equity securities rank senior to the preferred stock.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Distributions&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to any preferential rights of any
outstanding stock or series of stock, our preferred shareholders are entitled to receive distributions, when and as authorized
by our board of directors, out of legally available funds, and share pro rata based on the number of shares of preferred stock,
common stock and other equity securities outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Voting Rights&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless otherwise indicated in the applicable
supplement to this prospectus, or otherwise required under New York law, holders of our preferred stock will not have any voting
rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Liquidation Preference&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon the voluntary or involuntary liquidation,
dissolution or winding up of our affairs, then, before any distribution or payment shall be made to the holders of any common stock
or any other class or series of stock ranking junior to the preferred stock in our distribution of assets upon any liquidation,
dissolution or winding up, the holders of each series of our preferred stock are entitled to receive, after payment or provision
for payment of our debts and other liabilities, out of our assets legally available for distribution to shareholders, liquidating
distributions in the amount of the liquidation preference per share (set forth in the applicable supplement to this prospectus),
plus an amount, if applicable, equal to all distributions accrued and unpaid thereon (which shall not include any accumulation
in respect of unpaid distributions for prior distribution periods if the preferred stock does not have a cumulative distribution).
After payment of the full amount of the liquidating distributions to which they are entitled, the holders of preferred stock will
have no right or claim to any of our remaining assets. In the event that, upon our voluntary or involuntary liquidation, dissolution
or winding up, the legally available assets are insufficient to pay the amount of the liquidating distributions on all of our outstanding
preferred stock and the corresponding amounts payable on all of our stock of other classes or series of equity security ranking
on a parity with the preferred stock in the distribution of assets upon liquidation, dissolution or winding up, then the holders
of our preferred stock and all other such classes or series of equity securities will share ratably in the distribution of assets
in proportion to the full liquidating distributions to which they would otherwise be respectively entitled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the liquidating distributions are made
in full to all holders of preferred stock, our remaining assets will be distributed among the holders of any other classes or series
of equity security ranking junior to the preferred stock upon our liquidation, dissolution, or winding up, according to their respective
rights and preferences and in each case according to their respective number of shares of stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Conversion Rights&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The terms and conditions, if any, upon which
shares of any series of preferred stock are convertible into other securities will be set forth in the applicable supplement to
this prospectus. These terms will include the amount and type of security into which the shares of preferred stock are convertible,
the conversion price (or manner of calculation thereof), the conversion period, provisions as to whether conversion will be at
the option of the holders of the preferred stock or us, the events, if any, requiring an adjustment of the conversion price and
provisions, if any, affecting conversion in the event of the redemption of that preferred stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Redemption&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If so provided in the applicable supplement
to this prospectus, our preferred stock will be subject to mandatory redemption or redemption at our option, in whole or in part,
in each case upon the terms, at the times and at the redemption prices set forth in such supplement to this prospectus.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Anti-Takeover Considerations and Special Provisions of our Certificate
of Incorporation and our By-laws</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A number of provisions of both our certificate
of incorporation, as amended, and our amended and restated by-laws concern matters of corporate governance and the rights of our
shareholders. Our board of directors is divided into two classes. Each class is to have a term of two years, with the term of each
class expiring in successive years, and is to consist, as nearly as possible, of one-half of the number of directors constituting
the entire board. Under certain circumstances, at least two annual meetings of shareholders, instead of one, may be required to
effect a change in a majority of our board of directors. The classification of our board into two separate classes could discourage,
delay, or prevent a takeover of us thereby preserving control by the current shareholders. In addition, provisions that grant our
board of directors the ability to issue shares of preferred stock and to set the voting rights, preferences and other terms thereof
may discourage takeover attempts that are not first approved by our board of directors, including takeovers which may be considered
by some shareholders to be in their best interests. Certain provisions could delay or impede the removal of incumbent directors
or the assumption of control by shareholders, even if such removal or assumption would be beneficial to our shareholders. These
provisions also could discourage or make more difficult a merger, tender offer or proxy contest, even if they could be favorable
to the interests of shareholders, and could potentially depress the market price of our common stock. Our board of directors believes
that these provisions are appropriate to protect our interests and the interests of our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="hti_020"></A>DESCRIPTION
OF WARRANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Outstanding Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of January 17, 2013, an aggregate of
1,242,250 shares of our common stock were issuable upon the exercise of outstanding warrants, at a weighted average exercise price
of $2.53.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None of the warrants described in this section
have been listed for trading on any securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following description, together with
the additional information we may include in any applicable prospectus supplements, summarizes the material terms and provisions
of the warrants that we may offer under this prospectus. While the terms we have summarized below will apply generally to any warrants
that we may offer under this prospectus, we will describe the particular terms of any series of warrants in more detail in the
applicable prospectus supplement. The terms of any warrants offered under a prospectus supplement may differ from the terms described
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will file as exhibits to the registration
statement of which this prospectus is a part, or will incorporate by reference from another report that we file with the SEC, the
form of warrant agreement, which may include a form of warrant certificate, that describes the terms of the particular series of
warrants we are offering before the issuance of the related series of warrants. The following summary of material provisions of
the warrants and the warrant agreements are subject to, and qualified in their entirety by reference to, all the provisions of
the warrant agreement and warrant certificate applicable to a particular series of warrants. We urge you to read the applicable
prospectus supplements related to the particular series of warrants that we sell under this prospectus, as well as the complete
warrant agreements and warrant certificates that contain the terms of the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will describe in the applicable prospectus
supplement the terms relating to warrants being offered including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the offering price and aggregate number of warrants
offered;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">if applicable, the designation and terms of the securities
with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such
security;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">if applicable, the date on and after which the warrants
and the related securities will be separately transferable;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">in the case of warrants to purchase common stock or
preferred stock, the number of shares of common stock or preferred stock, as the case may be, purchasable upon the exercise of
one warrant and the price at which these shares may be purchased upon such exercise;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the terms of any rights to redeem or call the warrants;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any provisions for changes to or adjustments in the
exercise price or number of securities issuable upon exercise of the warrants;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the dates on which the right to exercise the warrants
will commence and expire;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the manner in which the warrant agreements and warrants
may be modified;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">federal income tax consequences of holding or exercising
the warrants, if material;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the terms of the securities issuable upon exercise
of the warrants; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any other specific terms, preferences, rights or limitations
of or restrictions on the warrants.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Before exercising their warrants, holders
of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including, in the case
of warrants to purchase common stock or preferred stock, the right to receive dividends, if any, or payments upon our liquidation,
dissolution or winding up of our affairs or to exercise voting rights, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exercise of Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each warrant will entitle the holder to
purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe in the applicable
prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise
the warrants at any time up to the specified time on the expiration date that we set forth in the applicable prospectus supplement.
After the close of business on the expiration date, unexercised warrants will become void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Holders of the warrants may exercise the
warrants by delivering the warrant certificate representing the warrants to be exercised together with specified information, and
paying the required amount to the warrant agent in immediately available funds, as provided in the applicable prospectus supplement.
We intend to set forth in any warrant agreement and in the applicable prospectus supplement the information that the holder of
the warrant will be required to deliver to the warrant agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon receipt of the required payment and
any warrant certificate or other form required for exercise properly completed and duly executed at the corporate trust office
of the warrant agent or any other office indicated in the applicable prospectus supplement, we will issue and deliver the securities
purchasable upon such exercise. If fewer than all of the warrants represented by the warrant or warrant certificate are exercised,
then we will issue a new warrant or warrant certificate for the remaining amount of warrants. If we so indicate in the applicable
prospectus supplement, holders of the warrants may surrender securities as all or part of the exercise price for warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="hti_021"></A>DESCRIPTION
OF DEBT SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We may issue debt securities, in one or
more series, which may be senior or convertible debt. While the terms we have summarized below we expect will apply generally to
any debt securities that we may offer under this prospectus, we will describe the particular terms of any debt securities that
we may offer in more detail in the applicable prospectus supplement. The terms of any debt securities offered under a prospectus
supplement may differ from the terms described below. We will file as exhibits to the registration statement of which this prospectus
is a part, or will incorporate by reference from reports that we file with the SEC, forms of debt securities and/or any indentures
containing the terms of the debt securities being offered. Any debt securities which we offer by this prospectus will be exempt
under the Trust Indenture Act of 1939, as amended, or Trust Indenture Act. Therefore, we may not use an indenture (and, thus a
trustee) or, if we use an indenture, it may not fully comply with the requirements of the Trust Indenture Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The documentation governing the debt securities
may provide for an agent to act for and on behalf of the holders of the debt securities. We will file as exhibits to the registration
statement of which this prospectus is a part, or will incorporate by reference from reports that we file with the SEC, supplemental
forms of debt securities and/or indentures containing the terms of the debt securities being offered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following summaries of material provisions
of the debt securities we may issue are subject to, and qualified in their entirety by reference to, all of the provisions of the
documentation applicable to a particular series of debt securities. We urge you to read any applicable prospectus supplements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will describe in the applicable prospectus
supplement the terms of the debt securities being offered, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the title;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the principal amount being offered, and if a series,
the total amount authorized and the total amount outstanding;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any limit on the amount that may be issued;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">whether or not we will issue the series of debt securities
in global form, the terms and who the depositary will be;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the maturity date;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the terms of the conversion rights;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the annual interest rate, which may be fixed or variable,
or the method for determining the rate and the date interest will begin to accrue, the dates interest will be payable and the
regular record dates for interest payment dates or the method for determining such dates;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">whether or not the debt securities will be secured
or unsecured, and the terms of any secured debt;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the terms of the subordination of any series of subordinated
debt;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the place where payments will be payable;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">if payment of principal and interest on the debt securities
may be paid in our securities rather than, or in addition to, cash and the terms of any such rights;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">restrictions on transfer, sale or other assignment,
if any;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our right, if any, to defer payment of interest and
the maximum length of any such deferral period;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the date, if any, after which, and the price at which,
we may, at our option, redeem the series of debt securities pursuant to any optional or provisional redemption provisions and
the terms of those redemption provisions;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the date, if any, on which, and the price at which
we are obligated, pursuant to any mandatory sinking fund or analogous fund provisions or otherwise, to redeem, or at the holder&rsquo;s
option to purchase, the series of debt securities and the currency or currency unit in which the debt securities are payable;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">whether the debt securities will restrict our ability
and/or the ability of our subsidiaries to:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">incur additional indebtedness;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">issue additional securities;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">create liens;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">pay dividends and make distributions in respect of our
capital stock and the capital stock of our subsidiaries;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">redeem capital stock;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">place restrictions on our subsidiaries&rsquo; ability
to pay dividends, make distributions or transfer assets;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">make investments or other restricted payments;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">sell or otherwise dispose of assets;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">enter into sale-leaseback transactions;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">engage in transactions with shareholders and affiliates;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">issue or sell stock of our subsidiaries; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">effect a consolidation or merger;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">whether the debt securities will require us to maintain
any interest coverage, fixed charge, cash flow-based, asset-based or other financial ratios;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">a discussion of any material United States federal
income tax considerations applicable to the debt securities;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">information describing any book-entry features;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">provisions for a sinking fund purchase or other analogous
fund, if any;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the applicability of the provisions in the debt securities
on discharge;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the denominations in which we will issue the series
of debt securities, if other than denominations of $1,000 and any integral multiple thereof;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the currency of payment of debt securities if other
than U.S. dollars and the manner of determining the equivalent amount in U.S. dollars; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any other specific terms, preferences, rights or limitations
of, or restrictions on, the debt securities, including any events of default or covenants provided with respect to the debt securities,
and any terms that may be required by us or advisable under applicable laws or regulations.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Conversion or Exchange Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will set forth in the prospectus supplement
the terms on which a series of debt securities may be convertible into or exchangeable for our common stock or our other securities.
We will include provisions as to whether conversion or exchange is mandatory, at the option of the holder or at our option. We
may include provisions pursuant to which the number of shares of our common stock or our other securities that the holders of the
series of debt securities receive would be subject to adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Consolidation, Merger or Sale</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We do not currently expect our debt securities
to contain any covenant that restricts our ability to merge or consolidate, or sell, convey, transfer or otherwise dispose of all
or substantially all of our assets. However, any successor to or acquirer of such assets may be required to assume all of our obligations
under the debt securities, as appropriate. If the debt securities are convertible into or exchangeable for our other securities
or securities of other entities, the person with whom we consolidate or merge or to whom we sell all or substantially all of our
assets may be required to make provisions for the conversion of the debt securities into securities that the holders of the debt
securities would have received if they had converted the debt securities before the consolidation, merger or sale.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Events of Default Under the Debt Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless we provide otherwise in the prospectus
supplement applicable to a particular series of debt securities or the debt agreement or indenture governing the debt securities,
the following are events of default with respect to any series of debt securities that we may issue:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">if we fail to pay interest when due and payable and
our failure continues for 90 days and the time for payment has not been extended or deferred;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">if we fail to pay the principal, premium or sinking
fund payment, if any, when due and payable and the time for payment has not been extended or delayed;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">if we fail to observe or perform any other covenant
contained in the debt securities, other than a covenant specifically relating to another series of debt securities, and our failure
continues for 90 days after we receive notice from the debt securities agent or holders of at least 25% in aggregate principal
amount of the outstanding debt securities of the applicable series;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">if specified events of bankruptcy, insolvency or reorganization
occur; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any other event of default provided in or pursuant
to the applicable agreement or indenture, if any, or prospectus supplement with respect to the debt securities of that series.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The holders of a majority in principal amount
of the outstanding debt securities of an affected series may waive any default or event of default with respect to the series and
its consequences, except defaults or events of default regarding payment of principal, premium, if any, or interest, unless we
have cured the default or event of default in accordance with the form of debt security and/or agreement or indenture. Any waiver
shall cure the default or event of default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The holders of a majority in principal amount
of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding
for any remedy available to such holders with respect to the debt securities of that series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to the terms of the debt securities,
if an event of default thereunder shall occur and be continuing, the debt securities agent will be under no obligation to exercise
any of its rights or powers under such debt securities at the request or direction of any of the holders of the applicable series
of debt securities, unless such holders have offered the debt securities agent reasonable indemnity. The holders of a majority
in principal amount of the outstanding debt securities of any series will have the right to direct the time, method and place of
conducting any proceeding for any remedy available to the debt securities agent, or exercising any trust or power conferred on
the debt securities agent, with respect to the debt securities of that series, provided that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the direction so given by the holder is not in conflict
with any law or the applicable debt securities; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the debt securities agent need not take any action
that might involve it in personal liability or might be unduly prejudicial to the holders not involved in the proceeding.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A holder of the debt securities of any series
will have the right to institute a proceeding under the debt securities or to appoint a receiver or trustee, or to seek other remedies
only if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the holder has given written notice to the debt securities
agent of a continuing event of default with respect to that series;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the holders of at least 25% in aggregate principal
amount of the outstanding debt securities of that series have made written request, and such holders have offered reasonable indemnity
to the debt securities agent to institute the proceeding as trustee; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the debt securities agent does not institute the proceeding,
and does not receive from the holders of a majority in aggregate principal amount of the outstanding debt securities of that series
other conflicting directions within 90 days after the notice, request and offer.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">These limitations do not apply to a suit
instituted by a holder of debt securities if we default in the payment of the principal, premium, if any, or interest on, the debt
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 29; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We may periodically file statements with
the debt securities agent regarding our compliance with specified covenants in the documentation regarding such debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Modification; Waiver</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We and the debt securities agent may change
the form of debt security and/or indenture without the consent of any holders with respect to specific matters:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">to fix any ambiguity, defect or inconsistency in the
documentation governing the debt securities;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">to comply with the provisions described above under
&ldquo;Description of Debt Securities - Consolidation, Merger or Sale;&rdquo;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">to add to, delete from or revise the conditions, limitations,
and restrictions on the authorized amount, terms, or purposes of issue, authentication and delivery of debt securities, as set
forth in the documentation governing such debt securities;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">to provide for the issuance of and establish the form
and terms and conditions of the debt securities of any series as provided under &ldquo;Description of Debt Securities - General&rdquo;
to establish the form of any certifications required to be furnished pursuant to the terms of any series of debt securities, or
to add to the rights of the holders of any series of debt securities;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">to evidence and provide for the acceptance of appointment
thereunder by a successor debt securities agent;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">to provide for uncertificated debt securities in addition
to or in place of certificated debt securities and to make all appropriate changes for such purpose;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">to add to our covenants new covenants, restrictions,
conditions or provisions for the protection of the holders, and to make the occurrence, or the occurrence and the continuance,
of a default in any such additional covenants, restrictions, conditions or provisions an event of default; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">to change anything that does not materially adversely
affect the interests of any holder of debt securities of any series.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, the rights of holders of a
series of debt securities may be changed by us and the debt securities agent with the written consent of the holders of at least
a majority in aggregate principal amount of the outstanding debt securities of each series that is affected. However, unless we
provide otherwise in the prospectus supplement applicable to a particular series of debt securities, we and the debt securities
agent may make the following changes only with the consent of each holder of any outstanding debt securities affected:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">extending the fixed maturity of the series of debt
securities;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">reducing the principal amount, reducing the rate of
or extending the time of payment of interest, or reducing any premium payable upon the redemption of any debt securities; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">reducing the percentage of debt securities, the holders
of which are required to consent to any amendment, supplement, modification or waiver.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 30; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Discharge</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The documentation governing the debt securities
may provide that we can elect to be discharged from our obligations with respect to one or more series of debt securities, except
for specified obligations, including obligations to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">register the transfer or exchange of debt securities
of the series;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">replace stolen, lost or mutilated debt securities of
the series;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">maintain paying agencies;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">hold monies for payment in trust;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">recover excess money held by the debt securities agent;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">indemnify the debt securities agent; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">appoint any successor debt securities agent.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In order to exercise our rights to be discharged,
we must deposit with the debt securities agent money or government obligations sufficient to pay all the principal of, any premium,
if any, and interest on, the debt securities of the series on the dates payments are due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Form, Exchange and Transfer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will issue the debt securities of each
series only in fully registered form without coupons and, unless we provide otherwise in the applicable prospectus supplement,
in denominations of $1,000 and any integral multiple thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At the option of the holder, subject to
the terms of the debt securities set forth in the applicable prospectus supplement, the holder of the debt securities of any series
can exchange the debt securities for other debt securities of the same series, in any authorized denomination and of like tenor
and aggregate principal amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to the terms of the debt securities
set forth in the applicable prospectus supplement, holders of the debt securities may present the debt securities for exchange
or for registration of transfer, duly endorsed or with the form of transfer endorsed thereon duly executed if so required by us
or the security registrar, at the office of the security registrar or at the office of any transfer agent designated by us for
this purpose. Unless otherwise provided in the debt securities that the holder presents for transfer or exchange, we will impose
no service charge for any registration of transfer or exchange, but we may require payment of any taxes or other governmental charges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will name in the applicable
prospectus supplement the security registrar, and any transfer agent in addition to the security registrar, that we initially
designate for any debt securities. We may at any time designate additional transfer agents or rescind the designation of any
transfer agent or approve a change in the office through which any transfer agent acts, except that we will be required to
maintain a transfer agent in each place of payment for the debt securities of each series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If we elect to redeem the debt securities
of any series, we will not be required to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">issue, register the transfer of, or exchange any debt
securities of that series during a period beginning at the opening of business 15 days before the day of mailing of a notice of
redemption of any debt securities that may be selected for redemption and ending at the close of business on the day of the mailing;
or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">register the transfer of or exchange any debt securities
so selected for redemption, in whole or in part, except the unredeemed portion of any debt securities we are redeeming in part.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Information Concerning the Debt Securities Agent</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The debt securities agent, if any, other
than during the occurrence and continuance of an event of default under the debt securities, may undertake to perform only those
duties as are specifically set forth in the applicable documentation for such debt securities. Upon an event of default under the
debt securities, the debt securities agent must use the same degree of care as a prudent person would exercise or use in the conduct
of his or her own affairs. Subject to this provision, the debt securities agent is under no obligation to exercise any of the powers
given it by the debt securities at the request of any holder of debt securities unless it is offered reasonable security and indemnity
against the costs, expenses and liabilities that it might incur.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Payment and Paying Agents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless we otherwise indicate in the applicable
prospectus supplement, we will make payment of the interest on any debt securities on any interest payment date to the person in
whose name the debt securities, or one or more predecessor securities, are registered at the close of business on the regular record
date for the interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will pay principal of and any premium
and interest on the debt securities of a particular series at the office of the paying agents designated by us, except that unless
we otherwise indicate in the applicable prospectus supplement, we will make interest payments by check that we will mail to the
holder or by wire transfer to certain holders. We will name in the applicable prospectus supplement any paying agents that we initially
designate for the debt securities of a particular series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All money we pay to a paying agent or the
debt securities agent for the payment of the principal of or any premium or interest on any debt securities that remains unclaimed
at the end of two years after such principal, premium or interest has become due and payable will be repaid to us, and the holder
of the debt security thereafter may look only to us for payment thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Governing Law</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The debt securities will be governed by
and construed in accordance with the laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="hti_022"></A>DESCRIPTION
OF UNITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As specified in the applicable prospectus
supplement, we may issue units consisting of one or more of the following: shares of common stock and/or preferred stock, warrants,
debt securities, or any combination of such securities. The applicable prospectus supplement will describe:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the terms of the units and of any of our common shares,
preferred shares, warrants or debt securities comprising the units, including whether and under what circumstances the securities
comprising the units may be traded separately;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">a description of the terms of any unit agreement governing
the units;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">a description of the provisions for the payment, settlement,
transfer or exchange of the units; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">if applicable, a discussion of any material United States
federal income tax considerations.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="hti_023"></A>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We and the selling shareholders may sell
the securities covered by this prospectus from time to time. Registration of our securities covered by this prospectus does not
mean, however, that those securities will necessarily be offered or sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We and the selling shareholders may sell
the securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">to or through one or more underwriters or dealers;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">directly to one or more purchasers, through agents, in
private or open market transactions; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">through a combination of any of these methods of sale.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We and the selling shareholders may distribute
securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">from time to time in one or more transactions at a fixed
price or prices, which may be changed from time to time;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">at market prices prevailing at the times of sale;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">at prices related to such prevailing market prices; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">at negotiated prices.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The method of distribution of the securities
will be described in any applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The selling shareholders may also sell resale
shares under Rule&nbsp;144 under the Securities Act, if available, rather than under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Underwriters, dealers or agents may receive
compensation in the form of discounts, concessions or commissions from us, or from the selling shareholders, as the case may be,
or purchasers (as their agents in connection with the sale of the securities). In addition, underwriters may sell the securities
to or through dealers, and those dealers may receive compensation in the form of discounts, concessions or commissions from the
underwriters and/or commissions from the purchasers for whom they act as agent.&nbsp;&nbsp;These underwriters, dealers or agents
may be considered to be underwriters under the Securities Act. As a result, discounts, commissions, or profits on resale received
by the underwriters, dealers or agents may be treated as underwriting discounts and commissions.&nbsp;&nbsp;Each applicable prospectus
supplement will identify any such underwriter, dealer or agent, and describe any compensation received by them from us. Any initial
public offering price and any discounts or concessions allowed or re-allowed or paid to dealers may be changed from time to time.&nbsp;&nbsp;We
and the selling shareholders may use underwriters with whom we and the selling shareholders have a material relationship.&nbsp;&nbsp;We
will describe the nature of the relationship in an applicable prospectus supplement, naming the underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Broker-dealers engaged by the selling shareholders
may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the selling
shareholders (or, if any broker-dealer acts as agent for the purchaser of resale shares, from the purchaser) in amounts to be negotiated,
but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a customary
brokerage commission in compliance with Financial Industry Regulatory Authority, or FINRA, Rule&nbsp;2440; and in the case of a
principal transaction a markup or markdown in compliance with FINRA IM-2440.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We and the selling shareholders may authorize
agents or underwriters to solicit offers by certain types of institutional investors to purchase securities from us or the selling
shareholders at the public offering price set forth in an applicable prospectus supplement pursuant to delayed delivery contracts
providing for payment and delivery on a specified date in the future. We will describe the conditions to these contracts and the
commissions we and the selling shareholders must pay for solicitation of these contracts in the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We and the selling shareholders may enter
into agreements that provide for indemnification against certain civil liabilities, including liabilities under the Securities
Act, or for contribution with respect to payments made by the underwriters, dealers or agents and to reimburse these persons for
certain expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All shelf securities we offer, other than
common stock, will be new issues of securities with no established trading market.&nbsp;&nbsp;If the shelf securities are traded
after their initial issuance, they may trade at a discount from their initial offering price, depending upon prevailing interest
rates, the market for similar securities and other factors. Any underwriters may make a market in our securities, but will not
be obligated to do so and may discontinue any market making at any time without notice.&nbsp;&nbsp;Therefore, no assurance can
be given as to whether an active trading market will develop for any new shelf securities. We have no current plans for listing
of the preferred stock on any securities exchange or quotation system; any such listing with respect to the preferred stock will
be described in the applicable prospectus supplement or pricing supplement, as the case may be. We cannot guarantee the liquidity
of the trading markets for any of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We and the selling shareholders may grant
underwriters who participate in the distribution of the securities an option to purchase additional securities to cover over-allotments,
if any, in connection with the distribution. Underwriters, broker dealers or agents and their associates may be customers of, engage
in transactions with, or perform services for us or the selling shareholders in the ordinary course of business for which they
receive compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any underwriter may engage in overallotment,
stabilizing transactions, short covering transactions and penalty bids in accordance with Regulation M under the Securities Exchange
Act of 1934, as amended, or Exchange Act. Overallotment involves sales in excess of the offering size, which create a short position.
Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified
maximum. Short covering transactions involve purchase of the securities in the open market after the distribution is completed
to cover short positions. Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the securities
originally sold by the dealer is purchased in a covering transaction to cover short positions. Those activities may cause the price
of the securities to be higher than it would otherwise be. If commenced, the underwriters may discontinue any of these activities
at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Because selling shareholders may be deemed
to be &ldquo;underwriters&rdquo; within the meaning of the Securities Act, they will be subject to the prospectus delivery requirements
of the Securities Act, including Rule&nbsp;172 thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any underwriters who are qualified market
makers on the Nasdaq Capital Market may engage in passive market making transactions in our common stock on the Nasdaq Capital
Market in accordance with Rule 103 of Regulation M, during the business day prior to the pricing of the offering, before the commencement
of offers or sales of common stock. Passive market makers must comply with applicable volume and price limitations and must be
identified as passive market makers. In general, a passive market maker must display its bid at a price not in excess of the highest
independent bid for such security; if all independent bids are lowered below the passive market maker&rsquo;s bid, however, the
passive market maker&rsquo;s bid must then be lowered when certain purchase limits are exceeded. Under applicable rules and regulations
under the Exchange Act, any person engaged in the distribution of the resale shares may not simultaneously engage in market making
activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement
of the distribution. In addition, the selling shareholders will be subject to applicable provisions of the Exchange Act and the
rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of shares of common
stock by the selling shareholders or any other person. We will make copies of this prospectus available to the selling shareholders
and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We make no representation or prediction
as to the direction or magnitude of any effect that any of the foregoing activities may have on the price of our common stock or,
if applicable, the price for any of our other securities. For a description of these activities, see the information under the
heading &ldquo;Underwriting&rdquo; or &ldquo;Plan of Distribution&rdquo; in the applicable prospectus supplement. We will pay all
expenses related to this registration statement, but all selling and other expenses incurred by the selling shareholders, including
commissions and discounts, if any, attributable to the sale or disposition of the resale shares, will be borne by them. We have
agreed to indemnify the selling shareholders against certain losses, claims, damages and liabilities, including liabilities under
the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In compliance with the current guidelines
of FINRA, the maximum compensation to be received by any FINRA member or independent broker dealer may not exceed 8% of the aggregate
amount of the securities offered pursuant to this prospectus and any applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="hti_024"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The validity of the securities being offered
by this prospectus will be passed upon for us by Stephen P. Mandracchia and for any underwriters, dealers or agents by counsel
named in the applicable prospectus supplement. Mr. Mandracchia currently holds the positions of Vice-President Legal and Regulatory
and Secretary, of the Company and is a Hudson shareholder and a selling shareholder included in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="hti_025"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The financial statements as of December
31, 2011 and 2010 and for each of the years then ended incorporated by reference herein have been so incorporated in reliance on
the report of BDO USA, LLP, an independent registered public accounting firm, incorporated herein by reference, given on the authority
of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="hti_026"></A>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are subject to the informational requirements
of the Exchange Act, and we file reports and other information with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You may read and copy any of the reports,
statements, or other information we file with the SEC at its Public Reference Section at 100 F Street, N.E., Washington, D.C. 20549
at prescribed rates. Information on the operation of the Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330.
The SEC also maintains a Web site at<I> http://www.sec.gov</I> that contains reports, proxy statements and other information regarding
issuers that file electronically with the SEC. In addition, the Nasdaq Stock Market maintains a Web site at<I> http://www.nasdaq.com</I>
that contains reports, proxy statements and other information filed by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We make available free of charge, on or
through our web site, annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to
those reports filed or furnished pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act as soon as reasonably practicable
after we electronically file such material with, or furnish it to, the SEC. Our internet address is<I> www.hudsontech.com</I> .
Information contained on or that can be accessed through our web site is not part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This prospectus constitutes a part of a
registration statement on Form S-3 that we have filed with the SEC under the Securities Act. This prospectus does not contain all
of the information set forth in the registration statement, certain parts of which are omitted in accordance with the rules and
regulations of the SEC. For further information about us and our securities we refer you to the registration statement and the
accompanying exhibits and schedules. The registration statement may be inspected at the Public Reference Room maintained by the
SEC at the address set forth in the first paragraph of this section. Statements contained in this prospectus regarding the contents
of any contract or any other document filed as an exhibit are not necessarily complete. In each instance, reference is made to
the copy of such contract or document filed as an exhibit to the registration statement, and each statement is qualified in all
respects by that reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="hti_027"></A>INFORMATION
INCORPORATED BY REFERENCE&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The SEC allows us to &ldquo;incorporate
by reference&rdquo; into this prospectus the information we file with them. This means that we may disclose important information
to you by referring you to other documents filed separately with the SEC. The information we incorporate by reference into this
prospectus is legally deemed to be a part of this prospectus, except for any information superseded by other information contained
in, or incorporated by reference into, this prospectus. Any statement contained in a document incorporated or deemed to be incorporated
by reference into this prospectus will be deemed to be modified or superseded for purposes of this prospectus to the extent that
a statement contained in this prospectus or any other subsequently filed document that is deemed to be incorporated by reference
into this prospectus modifies or supersedes the statement. Any statement so modified or superseded will not be deemed, except as
so modified or superseded, to constitute a part of this prospectus. Our SEC File Number for documents we file under the Exchange
Act is 001-13412. The following documents filed by us with the SEC are hereby incorporated by reference in this prospectus:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our annual report on Form 10-K (including the information
incorporated by reference therein) for the fiscal year ended December&nbsp;31, 2011;</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our quarterly reports on Form 10-Q for the quarters
ended March 31, 2012, June 30, 2012 and September 30, 2012;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our current reports on Form 8-K filed with the SEC
on June 28, 2012, August 7, 2012 and December 27, 2012; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">the description of our common
stock contained in our registration statement on Form 8-A, filed with the SEC pursuant to Section&nbsp;12(g) of the Exchange Act
and all amendments or reports filed by us for the purpose of updating those descriptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All reports and other documents subsequently
filed by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act after the effective time of the registration statement
of which this prospectus forms a part and prior to the termination of this offering also shall be deemed to be incorporated by
reference in this prospectus and to be part hereof from the dates of filing of such reports and other documents; provided, however,
that we are not incorporating any information furnished under either Item&nbsp;2.02 or Item&nbsp;7.01 of any current report on
Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We hereby undertake to provide without charge
to each person, including any beneficial owner, to whom a copy of this prospectus is delivered, upon written or oral request of
any such person, a copy of any and all of the information that has been or may be incorporated by reference in this prospectus,
other than exhibits to such documents, unless the exhibits are specifically incorporated by reference into the documents that this
prospectus incorporates. Requests for such copies should be directed to our corporate secretary, at the following address or by
calling the following telephone number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Hudson Technologies, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">P.O. Box 1541</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">One Blue Hill Plaza</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pearl River, NY 10965</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Telephone: (845)&nbsp;735-6000&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>HUDSON
TECHNOLOGIES, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>$50,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Debt Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>___________________________________________</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>600,000 Shares of Common Stock Offered
by the Selling Shareholders&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>J</B></FONT><B>anuary
<FONT STYLE="text-transform: uppercase">22, 2013</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="tlogo42.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Hudson
Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Prospectus Supplement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">June , 2014</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Sole Book-Running Manager</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>William
Blair</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Co-Managers</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 45%; text-align: center"><font style="font-family: Times New Roman, Times, Serif"><b>Craig-Hallum Capital Group </b></font></td>
    <TD STYLE="width: 10%; text-align: center">&nbsp;</td>
    <TD STYLE="width: 45%; text-align: center"><font style="font-family: Times New Roman, Times, Serif"><b>Roth Capital Partners </b></font></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 37; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tlogo42.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tlogo42.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`1@$:`P$1``(1`0,1`?_$`-,```$#!0$!`0``````
M``````@#!PD"!`4&"@$`"P$```8#`0$``````````````P0%!@<(``$""0H0
M``$$`0,#`P,"`P0$!A,```$"`P0%!A$'"``A$C$3"4$B%%$582,6<8$R"J'!
M0AB14C,D)1GPL='ADL+20U-CHS245=4F5I87$0`!`@0$`P4$!@4'"0<%```!
M`@,`$00%(3$2!D$3!U%A@2((<9$R%/"AP4(C%;'14F(S\7*2<\/3%N&BLL+2
M0U,D-(+B@Z-5&`FS5)0E%__:``P#`0`"$0,1`#\`[^.LC(^ZR,BP7X$GS"E$
M+[!)T[=N_KZ=$:VK%H8#C3:UZUX@8XG,X\(%:?"EEMLB8&,86=)0P_)6ML!`
M2DJ2XX$QELH9;4[,D+)_E".$>/Z?;TFW9=NM=(=S/**:A+>J15+A*4CY9R@T
MW2K<1.8TD_7P'C`[L;Z)RC(;G'-K<=L\CL("WH<[*K=+M1AM:Y]P;4+IWQ-S
M&9=5W9@>;Z!J?J.J^GK!U#W36*I-GVZI;MY44HJEL-N4Y4,)S3B0#F(5C966
M4&OJR`9#"9$_8(P5AM)O7D%9%7D_("QH;=9=4]%P.F@,5+*5O*6AN(_<M_N4
MOVVR![CP"SI^FG1*\]*NOVXJ<U-TO]I=I3YBTS1.-KD<@%#C+#(8P/;KW94.
M\M#25N2E(J_4#&N-[';K43PN:KD5N#DMG%6$,8[F+-0O$KA*AYR*RX:K&!+:
M;L&&U-H>!'M*5KZ])%EZ07W;-NJ-U5:ZI%QI58(<+H#B9`E24$Z=,Y#'*%1V
MMM_.1KIPA!Q\JE$@@Y^89#B!#@[7[]4F3W=EMQDK;&+;IXZX(]OC3SS@JW$-
M*]IN7C<YWQ_<8$T:+1ZJ`]>G_P!,?4%9=U5[E@O[C=+=6SHTK4TB9`E@E)),
M)VX=D5]13)N[*5NT!3KY@"I`$_?,I3@F(8;_`"77.Z7'D(4M'D2@>/VZI)/^
MT!U81LJ)FT0JC4`4D9$GOAGJKVP1;C(+:]Y!^OWQDG?'ZG3M^NG0Z)\(#73E
MXS$6KR6RT0HG0D=PK3Z_J.MJURPS@)=L#Z.42<3WQ5XMAI&I/C]/N_UZ]$=+
MFLX8P.E2:!`0>';_`)8J6E!0D^6@&NAUT';^_K;25AS(SG'+C0K$S2<?IV10
MXEM38\M5I`[*0K33]-3KT:-1RE35Y3WQMMQVA3I()'L_7'K"4('V)6/U4HZ@
M#_AZV7^;Q!]D;-6Y4X!)'A%;;C90LIUT!(.IUU[GT[]NM!E2%8\8VZ@4:-?C
M'ONH+9.A\1_'_7UM39493Q@-AP5DP(I/@ML'12D%/8I/H/XG^WK6HLF1PEVP
M(5N4BM(22D0FPAI/=`6.VA*E:I'^G].M&J#F$P3W1AK'*H:`D@'NA1#C:3XA
MQ).I[Z@]S_?T`^'"L'21A&V:5QI&/;.%E$D?:-=?J.AVR"/-G`;Q=`TI'U1:
M+44$>:%G7733MH=.^O1A*0K%)&$$/G'J,R4DG7W=GMA9/CI]P*0?^,>_1=UT
M-GM,*##S[WF(('LBI/MZ]E#O_'_1Z]`&L3EQ@TH+(CTI1_Q5?W'UZ&;>YF4H
M`4^M&8G%*NP.B%::>GU_7H32%*!)Q@%=2^`5A)D.Z/$J7IV01].XZQ92D341
M`0J*AT8)/NCPCN"I0'?TUZ+*K6D#$1@I'5G43Q[X4)2>^A/]AZ!17)69(S@Z
M5+;&/"*0/^*A7]IZ$TK=Q)@)50XKX4GW1\I25-J&A`2="-=#K_P]96,K6B2<
MXQEP51*2)0E'*/N*0>P[ZJU_3^/1.BIG4+FN<"N,IIDE8G"R'$*"@`=-._?]
M.E=:"1(P69J4U2M`A)EUE3FB?+4?JK7_`%]<FF4@:B<(-&B#(YF/UQ=-J"@K
M3Z*.O]O6*!$`-/!X$C@90IUS`L?=9&1]UD9&J6UBQ2P["SL9S,&#`]R7-DO*
M\D,PFTE:R?(?8=$_3IFUE^H=MH>J=SJ`I2LEN9$I<!^(4CP$=V^B4NH)2%%2
MCAW_`%90*_EDW(*Z8LXMI88ULI5SBM3$1Y^);[D.P5$*<,AEQJ1#QQJ2%LNQ
ME>2)802H%*AU!3]=N'J5N$M6E2T[7*Y8*<`*<."=;?;W0\ZBG9M+(2Y)59++
M`I3V'('$=OZ((N*G%<0J94:MB5F/TT&,)3[46N1$@HA*"B/Q6HOX[3(2`K[$
MI.BB3IWZFIP;(Z>[?-'7UE'24["2M22\PT[/,^511F<L!/MANI;N%X<2TUJ<
M0?*D)U*5,YRE/ZH8.-RWX_O7+M0UN5%,]F5^*8BJVX'@]J&P'G5)#:TA7;7N
M-.H;M'J7Z37F\"S66Y57Y@%Z`7WJ<,SG+XDU'PS[LH7'^D^YJ9KYT4U6VD)U
M:BET#_Z8GXF".KYL:PB?E,KC/LOHCR&9T5A327XCSS3J?;6L^2DE"!J#IZCJ
MPE'5/7JC6FO>H*JVK2H:J=P.I$@/B,U)!,_&7=#&JUU]KD:Q2RI*A@=6$SV$
MYQ$KSMB1L9W<P[(<?7(IKC^F)LZ':Q'BTO\`+C3RB(VA;)2MDA0"%$'NV?'T
M[=>)/K*?NW3WJ6S<M@NOL-<V:^4M:)R(G_`*>&4S%Z/3I0,;UVM5VRX(;=2D
M@)2I*3($3XA0SQR@YN*.^$7>3#T(G/E6;8K!K:W+V4`_BF4ZVXXQ(CZG0EU(
M/D0._;7KTV]+76JAZG;"IK54.%6XZ-D*>F0209`$E3JW#C^T`(JMU3V*]L_=
MSQE*F<5)/LF3+X4@2X2X2@JI6I'JXG4H3Y-)2I2?(@>6BP4@#ZD^@ZM&DZ1W
MPS@M+396>`@4.2G,SCKQ/AX[*W\W)K]O(67.64.@?LH-O.592:=JO7/88CT-
M;;V+LAI%LRHAEA:N^O8`D&&F2I20HR4KZL.,1]>.H5#9*I(J%)"2J6,I#+XI
MK$A#I[4[NX-O7MYCNYVW.0LY#@F55S%ACV00&;%F/90D2Y4%V4VQ>0*N8&P[
M$4%:LI<U2K[?372FN6>WZ>R%BUUXW4T*JF)Y2@2)>TC"15X8QD-U-S\-V>P/
M)]R=P;D8Y@^'5TB^R._=]Z0S7P(*T,+<6PPV\\6E>0)2A"E*)[`J['JGIEON
MA"`.8H@1S>-PT^U*-RKK<*=ILJ4<,`/:I(^N&8XZ<R.//+&NR.;Q^W)C;@,8
MHBN&0JKJO)*XUKERFQ7"0^SE-'0NH6L5;I3HD_X3KIT#>;94-?Q1)66$_M$"
M[1WS8=Z)U4#C2\C,%!3_`)JE^,//N5NAA^SVWV2[F[C7W]-X7B-1)R'(+B6C
M^7754-M*I$IUMH>7LL^>J@`2?X]=6BW.5"DL-#4XJ0QR'C+"%#<6X;5MAA3U
M84A*0<M./O4F-)X^<E-E^3N)V^8;'YW#S_%ZB\E8Q.NZEM:&$W4*)76,F.C\
MAED*<8B6S)5JD#171JZT3]!,.RURX3/V"$*P;LI-X@_*D<N9[`</8I<;MN-N
M9B>U."9)N+FUNFDPW$*JVO<EN;!F6XS5U-9'4_)F/LTT2PEEEA`\CHRI>@[)
M)[=$K:%U1T#^)/#Z8PK7JJ1M=DU;AFVE,SV2_P`T?7*&1XU<U^-7+!_):WC]
MNI7[B2,+BUCV1,P85Y7JK$6LBU@0$/L9#54]D'9+](^4E;"0KQU25)()4;C:
MZAI@5#Z0$N3E*<Q+MF,!XY01L.^;)N*H52M+0:@$9:98XX>=1/?A#ZYQGV.[
M:8AE6=YO;N4F*8?43+W(+20RM;$&MJHKLR7)=1!9DS%,M,ME2REI1T!T!Z0;
M;;W7*G0C%4^/\D+FX;Y:]KV]5?6%(:2E1F-/US*?#&(ZO^N;^-EE;R'>3M(P
MXR\ZT$'#=S7$N>VHI4OS<P,!6BP1J@J3V]>G8JQW`D3;$I=A_5$6'KUL]UI2
MDU-/,*(^)OA['HSV._+Q\?&=7%5C-!RBP],RYM:ZF:_=:/-\?AE^REM18Z'K
MNXH<?K:<.O.!'Y4B2W':)^\]QT"NQ5+0*U)QE]/NQS;>M6UZVJ0TV^RHJ5+`
MMGL&/XIEG$B.*Y%"R6.+&KE1K*KEP(,^KL8LI-A6SH,]H28<JLLXKLJMMXC\
M=84F2P\I*M=-/KTD52?EB@*S/9]LY1*]-=+9=VDNLA)`Q).@Y]DB1+QA3*;B
M+CU3*N[:?&KJNL8ES[*QDRO9BUE;!AOS+"?*U<;*F8T-E:CIKH1KIH">A6Z=
M-2K0E)*I=GAP!@2NOUKLK!>J2D(E^YPQXD=G#A$;-I\Q_P`<U/:O0)G)V@0J
M(XXTM;.*[ASF42PD@L&978;,KWFUM)*TGW5:G_#TIIVC6_$&E*7W))$C[$Q#
MZ^NNU35*8#["4Z3@5-A0(/9SHHC?,_\`')/?$6-RBQ=+JD.J0J3B>X41A/LM
M+>4MR1+Q&%&0$(;)^YU'D1H-20#TK;E33B;B"GV@C]*8(GK9MEQPA%0RH@C`
M*02<1D.;WP>NUN\.W^]V(4FX6U^:T^<8E=,&376]$90C3/:[J44.*#L4H'<M
MNI2I7Z=)+X33)(4F8'C^J)BL&Y+3>Z-*Z=22I:?W,`>T35^G"-FSC.\8VWQB
M^S#-;^#C6-8U72;:YO+*1XQ(<&$PY+F.%L>3KSC<=I12AM*W%G[4I4H@=!,L
M_-@!`)Q[/Y8XO&X[59VBY4J0E(_F`?6H1&V[\U'QKA2?#E'1N)5H0H83N6K[
M3H?(_P#V+V['Z]*K>U:I].H()\#_`+,177===HT+_(54L`ZI?$W_`'HBI7S4
M_&VG1*>4./D?J<*W+UT_NP;K8VE4M>93:DGO21^E,`U'6_:Y6$"I8D?WT?WL
M$;L%S7XW\HE7<;8[>2DS^?CD=JQR*-2)L::3&I9(F"-*349-':M'0V_X-.+:
M0V/<=1J1JE/2?44OR2R%RD/IAE#UVKU"L5[Q:<0HI5^Y(_YY)&$%9:7$2BII
MUO9RG6X,&(_*G2G&T)0TS"95(DNI0C5?9ELJU.O;H*E0:E8"?"'!>;BUM]LU
MZI<I7FQR`./:D?7##<?^4FQ?**FFY)L/N54;AU519K@6RJ20!^WV3L)N2U&M
MX\D,RF$--.).C8*3J#W/?HS54:J=.HRR^G"&[8-]4>ZU\JFEG*6`.`!_;5VP
M0;,HHC+?>=\G&&_"464I,0.E*BI31(]U8&FGJ>_2?3E;SQ;/:(=->@62F^=5
MP!./VY0$F,_(GQ#RS?'_`'>,;WCIK/>9.0WN''!FZS+/SF\AI%VK%G7*FP\>
MD4(E1':!]12Y-0XE*5*\0"GR7*JW5+#.MR6@I"I_9EGCE#3MO4:AO=2;>P4E
MWF%$A*<\<1)9P[Y>$'=7NAT.Z%9\0SY!7ME`6I!*P@I/ND:^OF`>FZE963/@
M8?B:4TR!/[PG],!&1Z[C<:;:9/`J8CUA:646LKX_W.39LAN&T"-=0KWBD>.@
MZ8VY]VW/:=&JOKZ2G-&G,\[4>WX4@F#"K/4N+Y8=6DG*0!@<[_EWLQ3OLL#/
MUV*Y$IR+^9B]1/RNLCOL/K97"E2*R.ZU&F@C1:5*U2H:=0ZUZM^ES#YHKRIY
MA\''12U3DI]X:EA"Y0],-T7-(J*-]7*,QYEM)Q&&15&H91R"7>IFT3''?=;<
MS$KV,MI5A#J64UMK`6C[5.-R'8TMIM?D1XJ"5#J/3ZF>G75RL?VVU9C<&&'5
M);Y[%6TE>DX*\[20)GL5XPI)LS]L(94_RJUKRE7EQ(S.J<O$81IM[R+S_`,4
MCWD/8%K`\&KV_P`-$#-,OJ*6[C.P@(<*'&QN&Y)L([3R6`M&J=74*"^X5J8E
MWEZB>IG0M:E[=VI;U[<!_AJKU,@#+!`;4KM,/[:.QMO[KJQ1W&ZOINCDSI2R
M'$$2SYFK3/NG@<(!7>KDAG&\4N&JQ2G"J2(PT],H(4^S/YCJBO\`F>[(9@O.
M-2$!&@"?;U3V)[]>>O7?U'[ZZQWJHW$]0MVRA<90W\NW4<U$T`@KU+;2J:N(
ME+#"+3;,Z#V7;E&W5LE-4M+A4EU2$H4D]@`6<NV![+3LIQ+98=6Y-4VPPVTV
M/R7DK+JD("T)#JM3H===>J_]-:NZ.;OID4;::AXNB:%*"1B>V7$Q+NYUTS&V
M7&:I>K2@C'N$N$3N<9*ZTK]@,#_>1*:L%TSQDHF/N&2X?S7T!3Q>*G`IB`UY
M)';_``#KZ+?3E07NGVR*Z^4Z*"S(9)4RA8<0Z0F>M0^($#"0X&/+K>2*&MW*
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M5K0%=X)Q!]L<P7^8T28V/\1?Q(K#KB<BW;4E#CL>,=6Z7`_N$R3V8(0-/+R!
M(.FO?I_;7L@W"TNE)E4Z4E*L)C`SS(&,4I]850C;]=9&:%Y=%0U'-+Q;3,J*
M5H"24XDRRC>/C]^5WA#L1PXV+V8SO<#)86<[<XBJNRZMK]L\YN(U3/G9/=V#
M+"+.LJ9\&8RMN6@:H<.J3ZC7KB[;)O=*^I(.ED$!)"D3/M$\(<^VO43TTV+M
M^@M3U8\NL#)"U&G>!,O,3-((.<XO.<7RJ\(>0G$W?7:/:S<C*[K,MP-OK:NQ
MZHG;8;@5\2UGO6L>26'GY=*TB.AL,DI62``-2=!T:L>TKQ35(J:Q(+0/[:3I
MEB"`,SP]D%.MW5S9.[MAO?X=KWT5553\M*`RM(<^$G45I`$P#X\8;;_+:L-?
MMO,HD%1-WLH5E:U.%0=B;EE\?>I8`=\CKIZ]%-^>2H2$8)4#[\(#]&!IW-G5
M;[B$FI;=`"I8@!"L!]43"?)W'9/Q^<L9`:0I0V4R5*"M(<`(:C-Z^+H4D_9J
M.XT(/2/MQQ:*]A()'FQ]QB8>N7(5TAN=W2D?F3;`TN?>3^(D&1[Q`%?Y>4)D
M<--RTJ::2I/([+ON;;:CAT#!MM%)94EE#20D+&NOJ?KT-O0.<]0;41-/NQ.,
M-KTSW8W78XK?E6TU@4L:YF:I2S)`]L2"_)*CPX#\NF#&;2VO8G<)I00XH%*5
MT$K56J"%:G7UUU_CTG;3IR:]H/J*IK&8S[H=O66]7.DV#<JHL)+K=.O2=9F,
M!EA$'7^6\;#^:\O_`'_&0MG&=DPEY:&P\4JN-T4K\G4I#BR4)`^Y1(`[=.+>
M=2\%!H$AH:I#@,!$"^C>J5?K5=[G=P'JQJH;"%*Q*`6R2`<,)B<3U<_&6#P;
MY8/>V-5;`[G:*U5Y!8Q6S1Y!6OD"$=NFQM9;BKHTA1)FX)]XEE%@NL:Z=_I-
M=*QU(54)HUZ5$8IQX1R:?$+PAV1YLY7O5C.]3&5_MFV^,[>Y%CSN'Y/.I;1<
MR[M,CCV4":A$.6TNJDHA-J6KR\BK4:`#7J3-U[I9L930,-IYQ`4HR49)/L[X
MHYZ<.C%AZG4SUQO]4X$I?4@-!"=."@-142#B.X>V)>]S?@2XHO8-?O[49%N5
MB6:I:,_&[[,LK1FF+Q[F/(;D0:^;C\J%"<D142&@I.@4&RCZG0%GT&ZC7UH9
M4.8")XS$O#NBP/4/TQ[7VQ:3<-N7!^WU31U$MMH.L#&7Q3!,OB$X`3X%.0N?
MXIR@O^+\FWN+'`<DPS+)+U7)M;&PH\<R3;5T/N6^-L6#TC]LC7-?*1&3':*&
MD(;&B>W2AN[\N=9IE4;*$.D$J(!$\>^$'TWW^[B_5MHN5WJKG2>4(2^``TE(
MF=)2,9REC'2WS'D+8XI\B''PY)#>Q>ZTTME333\V,]@N4NOP6'W5-MQGQ%2$
MI7KJGI!LJU"J&DD`"?CB1[L(L'UO%*WMAYVB;2AWDJR_F`$X\<SXRCBHX1X[
M\<,W$<K'.'*-W\5O(]W4IVZA8#%S>2U.Q"/0-L?F6KF-X];5TVP1+4I"W4K[
M:`>O4GO7&^T]&EVV*!5+S$D"79**#[4MO3+YM==U%=73L+7I;6AI3I),R4D(
M!,B98GO@DMYL$^%&SVVR.%L'O1OCC&[3K,%6(W.>XAO!D>*09;%K`D356M-$
MP8R;$2:EN0RRTA))D.(/H.F_;KE>;A6\NXCGL\05#LX0_MU[=Z%MVM-3M*K=
M8N1EH6*=P#XA,F8'#")LOA>VYV(PK9W<-_87D%>[[8UD.X6-N9"S;X](PN5@
M&65E8^I^/7XF^^[;0JG(73[VK[3+3@:)3JD+(:.\0FFJ"VRV&TDS(!X18[H7
M8*I>WOF14&HFD'60$E,LP!/&8P[\(]^?]]]C@DVW"EOP6K?>S;RHLS'??CIE
MP)#>1R'8\LLN-K<BJE067%HU`46P#VUU6=F,,N5A9?2%)Y6H3X'RX_68:WJP
M%59-E-UEM<4R^JH;"BF0)!2O4..<@8CG^+_XP>,/+[B]*W@W=@[A_P!5IW,S
MS#'OZ3SI.,U**BH8QTQ)S$019"4+8_+66U>1(+JNQ[:'-P7>Y6ZNY%`ZXTE(
M20$JD,_8>R&#TAZ#[:WMM%F_[@I6ZNN<6"2K2#+`XF>/&>'9!Q[E_!EP<PK;
MS-<JHXF\<FTQ?&\BRN&W;[GS9<(SJK'["=%K;,-U`\ZHO,I4I`[_`%!Z3J/<
M]UKZT,5E2\X.PG#'P^V'EU']/NS+=8GJRW4+=.^EI12M$B4E()QSPPSB,+_+
MP-,S^8>Y4EZ.P5?[ME\\4I)=0/<W!VY=6@.+0A;Z?-E.BUI\B$^@U(Z4=XVY
MMBV)?;0E+ZTRU#.9$Y^$1EZ7;;<:C=+])='E/T"`0E"],A)9D9#+*.O[<N.R
MK;C.W/;25G"LJ<U.I^_]GGK\O$DIUU_ATQK.7$NMI63/F)!]DQ.+K=06D.;>
MN`4`>5;WE(_=4E!D1WB/SQ^/,SDQM=76_)OCRYE=+4[+7.$+S&YQ=DN5T)_(
M3;N*=S:G9=9A)P65#HDQG["8V&0\Z&&W"I:_"5JJEM'(TO-MESA.<YR!,L<9
M8'QCS;Z5W[?1VY77:BK:ANM:JD!*T*!4&R2)F:9)U&:2,_*"93$==_`;Y4-F
MN9-)285.MX.%\B!C:[/(-O)JTN0;!;$UFHE9#B\U983;09/NJ?C0"$R?;U4I
M.@!,?O6Q7SBJFF\E/V#('Q[>)X1>':'45B\[=<MVX7%5%W;;&L.`JQ/80`,L
M9"<SA'/]Q?69/SG5B4EQID<O]]7$,%(:4W(:A;I,.R'/9#:'U2UI4ZGR\BA#
M@03JGIU7II;5IFYEHR\(K!T<NE5=.L553-5#AI6JDR3(`8.*&1`E[([CH*$H
M2\4G7R?62?$`G]-2`"?7Z]1EAJ4``,8]#6VJIH::IQ3BIX3E@G@!*+[K<"1$
MVK.-MK??7<*OW_RJ:DX]E,2#@M9:O2H6(NUDEM"$EJ)5+:$MQN8L%1FAU!9\
ME:]M>O,#IIU*V1<-P5#?4F_TBF4U*TA&AQ'E"B)391/#*<3@Q8K\+8RJPTZG
M`MK42-,P3P\QXC'"#?Q.PVMK8+L'!)&$LJDN./BGQ>;1I4_(=/D9#T"&F,6Y
M;JSJH'[@HG4Z]7>LS71NXMAW;2&JM*@".6NH!/\`3D/JB(-TO;P"RFE#LVB0
M9Z#(\1YB?9,&-WFR["H@/VT]R+65T5AV5,7-C>TN+'::*UN.25S7T^2"GN2-
M-/ITN[PWPCI_MA=;36IYQIII1&EQ(TR22)E2%3EAG`%EH:&H=;=?;E='-)4=
M1Q49#(&0\,(@XY%;N6V\&?S9CMBY/Q.BDF-C=4VZ#5%EIM#+DYZ.CQ8GN2W4
M*="GDK*/+1)``Z^??U)>I7>G5;=C]OK7/E+2VO1RU(840)#[R&D*^V+T=*[/
ML;;]M;-S0%UZ_,M?,<3.9F!I!(&D23AG*<,564RK6PC5=3%;-A;S6V68KS+S
MYGS'5H2PW5LQQY$LJ[O@_8A&A`'4:=,.FNY>J&X6=GVJIG:G'9?,):"DB>F>
MI$TN2G,"2N$3-N7=K=!MR=CDFUI2K3B%#CJ\RA/WQ*SLQQ`Q[';*DS#.)5A>
M9/`3&?DTT:1&.-P+1*0IO\9,>.F:ZEEI0"T/*(\]>Q'7L5TD_P#CIL/3"OI=
MS5UV:J*YM*7"$T]0V0?B(DJH6#(X3TD8<,HI?NCJ==KRV]24[B!3JF`HA,R.
M,L`,\NZ"EW@W#IMI\-L<@E/PHDN-62D4]:MQ+0DO-H2(Z6&%-LH7[*G2%!*>
M_G]W4Z>HOKGM[IIT[JK6T^DW5ZG"&\TF1!2?*IM0E@,"8C'86UKCN.]&E<FM
M*WP5*$L&Q(RP4#,Y3S$0#6=O,O)LJ98I>5:7DA^S?E./+=5&4])6\RX%J43Y
MZG0_J/7KYLK_`%UPK;^]N"L.+SY6#)/F!..0R'LCTZLEB18-N)=4)!+??A(8
M<3$F'QU42UR]R<L>@I7%FN0*^DM7&4^^4LL?]+LH?(\U-/24-J*=2`1].O:K
MT`[%<H&7]_%)Y5?3I92K'[BID?$1Q_9'MBCWJ!W&;LANB;7^&TXX5##$RD#D
M,L??$G=E[OXI]C7WO>;]L@))"]!H=%@I.A_7KTYJOX1EG**N5T]%-+$\U'Z8
MYC_\Q<)#N,<4GV7X"5MY-NHTTIQ;23[,^GQ%M"7(<IYMR3[HC%.K:D$*T((Z
MDK9E;^7TSE8G-(0.`S![8I)ZVFF';[MVDK4E5.4.E0$Y_P`1OBG(#B?"''^/
MWXP>#V]_#7C_`+O[N;,6-WN'GV$.3\MMW-Q=Q*9F78Q<AO*V.\W55V6(K82T
M1(3/A[*$`=E#[B=2UXW9>:FI<4IX(IPOR@H29"0EB`)XSB1=M]!.@MXVU0W"
MZ4R35.-9_,58F5"2OA="1V915SY^+K@WL1Q(WUW;VXV?7A^=87@\BPI;^;G.
M>7":J5&DP&X3T:':Y'+@R?=1(*"EQM04M?W:_0_8]QW.JK`Q4.A;&&24C'P'
MZH8'J#Z*=.=M;054[6I-+S;8(//?5+X0,''%3)GW^R&B_P`MM)6F-S+C);<T
M8L-C7'W9*&XH*WX>ZP=0V$/R0XJ&8Z`K0C_&->DO?YTU*0<Q]A$+WI"MZZ39
ME<1D7/\`4,3!_)E)<_ZOGEBVEEV2I.Q>430PI'BE24?CM+:?4S_-2005GP/9
M/2/MW&X,+'F!<T]GW28E[J]1KJ.A-S.H@<@8@"9DL'+Z<(Y[_BW^4;C=P@X^
MY7M3N_6;BW>3W^\%_G=8C;K&JNTJU5-IBF"UT=Q,JQRYA]Q+JJQ6BE)0"D_X
M0?1T7>W.UE7\PA01,:3J$\!/$2.45VZ'=?*79NPUTUX9D&E.2DXG`!0&/X4P
M1G+'*4S!.\K?FWXD;[<:-_=E\:H=\<?RG=#:C.,/QR=D>#T<:L<G3:IZ/'==
MF0,GNBE)<<'?\<=N_CUU:;"\FM:J%+2III>J8!]V?Z8<6]/4O;-U[#K:*SLJ
M>?=0M``6@2PXZFD]G"-4_P`N-7/PLGY>6S3;C=#+K-G::!8^Q,5$EV-9/W#E
M2XT>=*BQVY2S'M&%+\$`-*64_0'I)WMJ<=+I$I:L/;+Z>,">B^WOG:]XK"-2
MG7FSX\HSXRPRPB<WG_)>8X%\L7O9#RHVP&ZKKK*%)+WF,4M5-1VVM4^:G2-!
M]P))Z;6U5_\`[9M2A(EP8?9$R=3J1^IZ17%!\I52NSGP$\OIC')C\2_.39K@
MYEF]65;Q0=Q;:IW`QG!*:B9P?%:ZSF!^AM;Z5)==>>RFN6$>$Y*"WX*'VZZ]
MSU)N[-MJN=3\PUBM3021CB!D,XI-Z?NI.UNFY>I+[I2^MXG5S%"0U3R"3]/?
M$E_(C_,#[1V^$WE1QWVPW*<R2XPW,8<7/-R&\>PBGVTOFJR1^QY-(QSV\P?S
M"#6O>4N3'0N+YMQO#[U.`I0[-MANW.?,/E+*4D3F%*)''[V&6.$3)U/]1NRM
MPM(M=G0:BN=&A.EV6E2B$I'F:QF3@`H9RAD?@?XA;EVV[LGF59SDU6WT*DSO
M#,3CJD5;DO,[?(7D1;N>FLAR;4UU?0NQO$/NRU/27@H>VE`'7>[Q1H0S\G(@
M)5J&/'+/WPVO3?M1:;X_>*)L(I7%!).HJU`B1`F?NG/`1/G\AN[67[*</-W]
MRL,PO'MTK[&:"J;.(Y95V=SBF0UUG?U>.9LO)*BE>BSI=+&QNSE27&6U!!]K
M[AX>0+6L_P"'4^;B(M=UH9%)MDNU">8E*<4D8*$A('/N,<I7'_?[XT,IG[CY
M'RZXD?T_DEA=05U=)Q>&YM=B3\"Q@IL;>TFU+^Z=3C]4AN[_`)+3,)ED(/8I
MZ?MS1<?RX?**`9)F<`?8)F*.T+O21\(/51H)M?-_#/->:',EPY&,I8:<HW[=
M/='X,9^"YC"VNXW<B*C<*9BN11L,MK1S,9%;69B]43&\9GV+,C=^<TJ'#NU,
M..^3+J/!)\DD:CI'V^FN%9YE`XB>'#C!K=S?IL;M4]FA)K="M$JFJ5YI'3@Z
M3Q[8//\`RY"BC;KE&X?978IW)VS?MID:69*?;?Q&S5%C19ZVA)EM"6W_`#RZ
MZ^"3HI1T`Z2M\!"JLI49*)E]/&)[].E?N%&U7"$G\L2I,C)$]..6!,LIGV06
M'SX0)]IP6COL0GI#%+O+MQ;749J+(F"!!#>2,.R)'XS3S@C^]-;#BO%24)5J
M1UK:]1RU%?\`O-/O&&'U0#ZNZ2Z5NR6'60=!?:E@F22$+FHDYA.K+C*(QOC%
M^5CC%PRXQ+V;W)A;J7.5N;L;AYK%B8'B5==5;%/9,8^F.V)LVYQ8/-!R,HI"
MD]]-#TX+Q:7Z^I%4R/B;2F7$2GWRXRAM]%^L%+M'8;-LO#@0XE1\QD`J8`$@
M$$B9$\^,&SN%\\W#+.\#S?#**@W^BW&08ADF-P9=EMQ2M5J9UOCLZ%&<FNC-
MTA]I#TD:ZD_ITDT%@535X*\%ZA]7C#QW9U>IKMMQ[E/<Q2VBD8`?$DC]D83,
M1S?Y>5Y4/F'N1!;2PZ]$XT9!*F:*+5HW&_\`Z%MJW':ET87(:B>XVAU84F6L
M]]`G331T[[J&V[.VE8((Q\0GQB*O2^S=7MW/N)Q!PF`DCX^W#,3QD)1U^;A.
MR%X!G25/,>TYA.2J0IY)9;6PJ@G!;C;@4`T"\K4^X3H.HOM?G=:<X%Q)^L1=
MK>P(LMT01YA;'\/^P>,<QW^7CQ2JR''N95!>U]+:TMHC:ZAO*R?(@74.WIU,
MY]#N*NS@10&IU?(BR?:4B0'$EMU:2/%:@7ON6J"%-+R"=7O('ZHISZ8-L*J=
MH792TX*KFAC/$%,^W$&9BZ^1?XA=P\?W#_WC>!6.2L<MX<M-MD>W&#6(Q*TH
M;=QM*8^3[6RH,B*JL:`;!DU;!CHCM`NQBD`LK%L%\H$,-M/J&M6!F?\`)Q@S
MO3I%N=6Z;M=K$E7RZT-S0$IS`^),U"0/$'+,=D1>?&1,R*?\EW&BRR$6MGE+
MNZV5G*UW8DO9+'OY.%9S)N)U\N7*8DMV<J>\ZY+1(;4\S(4MMS[T$=*.XZE#
MUN<`_AE)EW#'].<07Z=K5?K=U@4FH0HN(<_$5)(!,\M,\"DC2<9$B<=^<)U+
MGOH&@6VZ?-OOY(\AJGR!]"H#^SJ(4)"5*E^U'JBRX^ZF=0)*!D,LO"+[H2!8
M#/>?BA@6ZTB1?MRI6+91(C"'(MZV.W8L2V4`H3^;"6SXNK#*BWJE:#[9(_CU
M3GK5Z0;)U5G4-J10U@)4#3J53`GA,-,DG[8E;9_6.Z[8;%,W\N_3A0(#B4J*
M9<`9Y'L,!<>!>Y$"=(?K,TQ`(8*C7V,0W=+93"E1]E<P1&5AB4ZD`N#R4`LG
MN?7JCUX]!?7JPUW,V5>G4LI5-(<J;DK_`$&0/LB<:'KSMRJ9!N5OIU.*^+12
ML8=I)*L?TP-6Y^(;L[8S?VW<*[NH`MV)3K+T?)KFUA7%52#_`*62\S+D>(:E
M)>;]D%M/CXGL=>JE=::#JMTFN[6VMTW&XNW6H09@U-46RI1TB2'EI(1J(PTY
M1-&R;UL^_K-18::B<=24E053M'258@?#G(>$,ZY&:C-/EUYPEN/'+:(K@><;
M=DO>,5"F6_!)2IDIT3ZZ'N>J^U=LOK-]IV7V^9752Q*:"=0,AAJ$R9^V);JK
MM36=G76T]"EN1/\`!0)8]\H>G'-KM[Z>PJ\CQK;_`'';E0$./T=S7XU-D*83
M8,->_)ANMQI;"%O(T&IU4-.K'W+H9Z@+2PW46BBJ-2T)4D4=/5H<`4D$8MH2
M09','.(KWAU"Z87FWN6NYOMH64Z5);=8;'LEJP[\(V2'M9R4N';%Q-1GE8_%
MBOSI,S*;>QQ8/+<=<=>=2]-F0$RI!.N@2V0!VU^G2U3]#O4E1V%R]7V[7>@H
MD)*RW45-R:7I2G(!P:<>\XQ$M'<>E[+@4A06TM>@2+;AF3@)(!]\I0Q=[+NY
M3B(M[<7=P82W6/8N;-ZR$66TL(F(8<7-DI4VI:$Z$:`@?7JN5^W??[T!17&K
MJ7J6E.A1==<6203+S+6K.1SE$NV?:MO9N"*JQ,!+,O.2D9X'`I3@)=L64&/)
MG2XU="2MZTL)D:+`8\?=\W5NA"&T,]EN(;\M5)'TZS;FV]S]3+G36"STY<IT
M+*0I#:R0%''4I`42>S"'AOS<CUOV^NG*FD@(QPD?TB)_=A\!&T^UF+X](4TN
M9$AR9MLZPT&/&38Z3'?*,3[CBD@%([ZC333KZ+NA]AH.BW1NV6B[-NI"%%6)
M`7,I23,N!LD892CS$W5<WK]>WT)*5))EAV34,,3F3XQHECS.V(8F2(#^36K;
ML"Q>B2$##LM=4W.@_P#*)2Y&J'67&P4^OEI_;THW7U#;08<Y/*J9`R.+/`\/
MQ<H)N[3?>2VEUMQ7+*5`IU2F,1/R\.(@;=][SX_>3<;&HV_V-,;IP<1>DR*&
M'D&$9VM,!^88Q?>9,*MA.!:U1&]?N'^'I;8]4.U[99EJIZ>L=*BF:4)84OLF
MD%WLSAD;KZ.[?WKN"AOE\IWW+C0(6EH:B&R'""K6C2=6($NR'"VXWZX@[2X=
M1;>[>NW.*X1C,5,&BQNMPW-E0JV$F;*G_C,)F54EP-*D37-05$^*M/ITB/>J
MW:COF5:[OK/:W3_W\.U_I<^[2MI12/(IVAY=*2E/U(E%SN1R&XE[KXA?X!GL
MR]R;#,KJY=+DE#9X7E[L.UJIBV7'HKJ4TH(`4PGP*2%)T['7OUE-ZK]L4RTK
M9MEU2ZDS2HML:01D5_C_``]L#W+IZ_N:RO[?N%)SJ5]O0=*/.!*6"B@D&6$Q
M#8;#Y#\?7&%B]C["XD-MF,F+2KW]CPK/2_9JC^Y^,J2J;!E!Q<;WE^V3_A\U
M?J>AJ[U36.]*G7(<*^T!D?VIAN[-Z"738M(Y:MKT+Z+>ZJ:@M+KAP$L#IPPA
MZLEY4<7\THK#%[^UO;*CN*]^INJVQP;*GH5O6R6_:DPY[*Z)Q#[+R"?(:`$]
M#T'J2VW1+2\E#I*#J$N2<9?UL+&YND]^NVW'-LUM*Z+8Z`%@H6%$3GGI^R`5
M3QW^&U1D"1QQQ`K=+J3+9V_W(;E*0X\IXZN!(2DE2O1*0!Z```#H%_UCV#F3
M3;[R9'$<NF*?`<[+LAH.>G7;B[-^0IMCGRJDR42DZB3F=00#,F/&./'PSU_F
MN-QRQ];Z_=(=.#[F.*074^"]/N`0%`_0=;;]9EH"@44-X;2.`;IQ_;0!:?31
M8K-0N45LMJ4H7.?,"U9B691!;;/;Q\)MA</KL#VAK9V!8A6.NR(=!2X'E[<4
M/27G),E4EV14/S)?E*?6L%QU13Y:`@``$J_U<[9N2RJJMEX)(()Y;`F)_P!?
M#DVET=<V/1/4FW:931J%!;F"BDK"0F:?*"`0,HVW,N3G%'/L5OL'RZ5<WV*9
M1!=K;^DGX3F*HEE"D)4B3&>#52VXIJ0A92L:Z$=NB=O]56T+:YSJ:V7GF`S'
MDIS^E^%&Y=+:N\6)S;]RIWE4#J2%:=:203,XZ?H(!9GC7\,[3J'?]WC'W%H]
MTH><PO<\O)4^KR="="EL)\O0>/;I?=]:=K?5K7;[R%98-4X$A_XWOB-;?Z8=
ME6BE-(S;E$E2B5.$K5YOWBB>'`9",W4[(_$/C>0T^4X_L+C4.\H;*!;U<R3@
M&XDU$>?6/)?AO.0Y;,B#+0VX@>3;S3C3@[+2H$CHNKUB[<?&FIMUY5[&Z<?V
M\"TOIIV/35B:\V]0J$*!!&4P01,%L]D&UB_*?B[BM<:S'9;V/06UR7&(-'MG
M>4=?'7+7YO+8@U.,PHC:U$Z%01Y*]5$G4])__NBVS7*_"H[DRA)_WX9F?YOX
MQ\8DAO9]/;E-BBIFFD-SD$(",^W2A(,7ECRQXV6U3/I+'(+B;6V<=Z)-A2<(
MRUV*_%DMK:E1W&ET12MF4TXI+B2"%`]*#7J9VNTX'4M/:A_4_P![&;@V*]NR
MA52W.G>71*$CH!&!$L])@"97'+X=9KGY,W8;''Y'Y4V8/##]T&&3(L7"[-<6
MPQ[32P^ZHJ((*4J[I`Z4E>K:VD<C0X*?LTL_WT1:SZ7-HO*T4-M??<2=0#A4
MX`1QTZ/LA$\;?AJ0DJ7QYQ7R`^TQ,,W12YW&A\B5=]1J#^HZW1^J2PMO:V$N
MH6<R>3_>PJ*]-%KK&Q37"SH2TGX=#2D$>TZ(,/:[?#A5LWBD/"]K*@X)C%?$
M1$C4M!MKDM?$6VR26%RW&J(3)[[`)"%O.N*`)_7H*]>H_:]2E=96-5=0H2FE
MODE9_FCFB'U9.DSVU[?^4VJD<10$2(*5$^_0(V;*N3_%3-\?ML5RV==7V.7U
M:_5W%-8X+E4F!/B26G&'D/-N4:E`K9=*?))"DCT(/?I%IO53M:E*2U;+N"G*
M;;&7?^/C&;GZ85N[Z`VB\TJG+:K-(0H'LSTF7AC`'N<:OAL?8;C/<?Z%3#+:
MVF?##=S@L-K5Y+0I9U44J/KTMI]8]G;(Y=MNY/\`54Y`]GX\157>DK9-12(I
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M?5QMFX@!^UW8('8VP,__`!X:VR.B=/L.A>M>VF*@4;RTK6%J6XHJ2)`STB6&
M8R]D/VYS'X[+>1)&1Y*EY!)*TX7F"?/R()"]*<ZA0&GT[=AVZ)TWJBV=3E2F
MK5>3J[4,'W?CQ(B=L7QM"D*I<%2F2V9X"0QTP,C;/QJ)WN>Y'M[=QHF]TBT%
MV_N'7X)G5?<NVHK9M2J<MN'!8KS)>A3W0ZY[/F\XLN.%2R5%45ZM=NN,"G-L
MO`:`EBVQ^GGQ']KZ)4=HOSFX[;1.)NKBM2E$$B>)^$(`S\>^"MC<V./<5/BC
M),E<'@TWJ[A66K5HRDH22K]E"E*(]22>DESU1[/2K&V7>9[$,?W\/,[*W.\H
MK#"L3P;7_LQ<_P"_'Q^__(,@_P#TC+O_`*/T'_[I=G?^F7C^@Q_?QK_`NY_^
M`O\`H+_V8)]M+.A0V7$IU(\=/``DG7T`/?7JP1I-Q-G4%)7[7%0TC9FD#,CC
MA+]4>K@^X@(\0X@$%/DLZI(.NNHT5K_;URJZ[CI%A')8)[9J,`&B>;)#;[TO
MYTH@YY<9I(R/?+(ZY424BOQ=**)U4I05"\V6DN/B(E0\TIGA\!W4_P"R--.O
MG=]5.\*GJ5U`OE;7$)N-FKW&4`%7PMJ)'QE2IS3DF0P&$>A707;SEMV_3W-0
M_#>;"RJ0FJ4Y3PQEPQ/MC2^.NRJ]U]P8E=(3,1BE,['M,FE1%M>^MB(\E45E
M"E(7HMYXA(\NW@A6GTZ??HKZ4+ZZ;L-;?4!QFUE)25A*N&K-U*P<1]TC/M@;
MKUOI-%:"BB5H?5@)3&)QX*[(FTRC,<4VTQQVTOKF%1458U%@JDS'E!$19\8U
M>PV#]ZG)?AH`"=21U[2WO='3WIC8%[EWN&FZ1M*4Z`AM2P&DZ?*A12K$`&7'
MA%"[%;KQN&[<X<QP.+4=,R03.4S,'#&9,0]\CN0MCO79.TK49^LP"J>\8$!T
M^W,NYD=P^=O+EME#Z&5J'BTVA24>V!Y`JU/7B'ZL/5[<^JNYS;>G#K]'LQE.
MD<OG4ZW<PKFM!U2")=@B\/2_HH:*E%PO;;:ZI1!(.A2$`&:2DE$P2,\<X%=(
M'BI"5L^3(4ZW'1&'O&.7$(<?/LI2IYB(%#RUU62H:'UZJ@\RSN6BI*"PLK5<
M"D"HDV05.3.,T@E6>9$62^<M&V;:Z"4%1QGY<"!W$?01)3PBV"7/M[3<S,\>
M>:C0%LQ\);N(3D=UY[LZ[D,1IX#_`)J\TKP;"AKVUZ]6_0-T)KMOJ5N'=U$G
M6HA2`XB8GP^-M)E+OSBC76?JBY<7?RNVNE*"2%RG\,LAYCC/LB4IZ`T"E3P#
M[R/$)?6VWY@_?I]B$I;'B@^([>G]_7J[54-LN:?D;@PRY2-@%(6D%()F#(*$
MI@2RBJY?51U!J5:M+F&$SE_+&.?JJ^,T]*;KH[KB0I2(R6&&TONJ[^*?L"2\
M\>P)U[]-"IZ6[$JW-2Z*D$SP:9S\4P<>O]2&"4EQ1`[%3]@QB.7FQS@S_B"L
MVU5PRSC=_;:KQ;^I\QW7ILGQC&L0PL?FLPA4VR;2%)FOS77GT`%L>/WZGI?L
M?2K8ZJE-.U;Z1Q12<.0R?<-&?OB(NH?5FMV9M]^]NLO*0PMN>E+A`"E!.,B.
MV6><A%GPMYM9SS`BMY;/X?YGLMMK;XM)R;#MT;_*<6RW%LM5%MD5BJR!$HX,
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MD'$O:KAEE_(7<3&Z;&<@G,8-EF+T,ERIR&@8R-R?&J;N`IU^-5PWTI>(=_Q_
MITN-=(NG09"E4=/J&<V6<OZ$136=8]Y_X@59@UK?"04I0MXDDC5*6HX:8>'@
MWSDMN8]AO%#R+C5FFP[^TEU`H5G)+*!?5^47C\F_A7=#43XM+611=8E8T#D6
MPCI4\&GUA(61W)E[ISL)E.AFS6]1`^_2M`R[?AQ&&>4.+8W6W<.Z4/\`S%O+
M26%*!/+?!.E6DR)5(F6,7=I\BFVV+\Y5\)<CV\:JGVMOH>=R-X[BYH:C$H"9
MV-2[^-53*VS0Q++SKL8,!P2`/)7^'HC_`/S#:CRQR[-;\>RF;E[]$&:CKOMV
MBOPLEXJ76:@Z3A-(D1.4UN``\/Y8<*CYDX)F'+6JXI8OC-1DDBPV9N-VY>Z.
M)9'CMYB=7(I\F_ITX<]6UQE35W%@A/Y;9]](0RH`A1&I,U/2_:E#2)J%V6WD
M$3\U,W+.6>@0I6'K'0WK=-38*%:GF&9E*QJ42D#B4K*=4YY=T:_S6YS8-P?J
M-M<BS?;>TRS'LXW$;PFWG43]:FTQJ`F@L;Z3=1:61&][);%#5>4(K6'65J!*
MU/)2@]$:;I[M&H(*K);QJ.&FF;/MGY"<LH3]]=;D;0J$-.H<T+6$STN$#MG)
M8D99#C`_[L?,%QXPS'>.N4;;8J-YZ;D-E43$H+&/7%-0Y)A%C+F5$%Q65T%I
M%D36$UTFS4V\$_85L*]M:TZ**M4=)MJT[//-DH3W&E;E_H0EVCKW07*\T]LU
M#74)"@!JU`'+4"O"?>(.?E7R1PGB-LGF6]V88Q)R"DP]$-J15U,:._*>L+6R
MC5%6R_,+:6:Z"[83&D.R%(<2TEP**2`>D!KI]M"H7,V6W!,Y>6F;G/A]SMAW
M;ZZG)VI3"I45%$Y&6HXSD,E"0GQB,]?RY;RIVB;WTE_&+N_!VG_I6)FTK<![
M<7;[^EXV(S8+%C&R)F<BM4[85KT9\%*D-H5J=-.E-[I#L6H"0];Z!L@F8##(
M5*4S@4<.^&54]<%TVVJC<)9>^5:0@I.EP@ZCIF3JRU88>,28\;>0&(<G=DMN
M]_,.Q^358YN%02;ROJK:"VB5"$&PLJB5'E+2$M.I:L:AYOW4@`^39\?NZ;YZ
M3=/"]\LFAIBXI4A^"QC.>/P</UQ).V^HS5]Z>KW@UJ"=)(F%`>4@'[Q.??E/
MLAEN"/.G#N=E+NU?8]M9*P*%M1N`O`7DW=A4VZ\B>2P])1:UR(L:*8S#C;6J
M4K\B1Z'H>OZ0;"IFD!-%2R5QY3,P1A*>C(^^$+8759W>M`Y54*M#R*DM9J2,
M.\K)G@8(3DWO3AW&?8G<#?3)<>38X_@-7&GS8%?"9592'K"S@TM;'2A*5!#+
MEI9LAYSN&62IP@^.A!H.E&P2^$O4=-IXR99.']"%O?>[-P[:M"[@VM)"4S!+
MB\S@,B,)RG$4]+\M&]]KM1(WTJ/B_P!X[S9R/B;V;#<ZNW$V\<Q*9BC;3[KE
M[52'H#<J?!88CK<=5[39;2GT/3@;Z5["%6ANEH:1:SDDLM$J]@",<(CFAZL[
MD8VI4[NN+:S;J=.HJ"W""F83,`JQ\V!QB33BSR'POE=L5@._.)T,G'Z;.(E@
M54ES%8_/I[2KF/U<Z`Y[;:$3DQ;6"^VI;?B%)0".MU?3S:=*_P#+FS6W5.6-
M.W,=D_)A#YVWU6%]VZF]("QJ'[+DIR'[Q,ISXQ%I0_-!DN:6.Y47;?@+FV<5
MFVF<6&"S\FB;N;84E#,LX5K/K8X>FWT2`*R;8,UC\I$-0=>##:M22.CU#TJV
MK7IFQ:*+5/\`^U;'M^Y]<12]ZG:$53M,EMU09)"CI<E,`Y>?B1[IP<O`'G%3
M<]<"S?<"'M,O:EK`LO9PVVHK2_J,HL?W%W&JJ^)+M3"B,`)<L?;TT[I3J.DB
M\=+MIT5:EI^RVU3DSBJF;G_H")2V+U1IMT[>7>&BL(0D8>;B#^\2<C'FU/.W
M&MV^9N]_#*-M7*I+;9;'I%[)W$>M:I^EOE-*PME$!BF:B?N4-\OYK'\BM92$
M@]9=NG6U*:@YOY/0+04X`T[93EPDB"VU.JS-\W2Y85:@MI7FD%3`P[5'&<^'
M9#8<V/DJ8X;;K[8[-0N/$K>7+=U,8E7V/1Z;+\;Q-#,F)>N4RZR=/R"*8+*2
M$>0DJ6AI1[`=&+7TLV=7-H5^34(4I(P12MF1[#Y#*&3U-Z__`.`;H*.H0I3:
MR92#DY:I<%@3ED.,.)Q/YC;I<E<JL*S->%>;[#X?74$BP5N)>9S@.9XS.OFY
M-<RG%8*L13*4;,-32Z0M0U:2%:`$=<7/IKM&UJ+9LUN*M,Y*IFP9=LM,/79'
M5=W=%M37):=0#G@N4Y3E/4<9$3QXQJ/.#Y(\-X89IMOMFQLEDF[^X.Z$6=/Q
MO'J*?CN*178<&QCU/M_U#DGC5+LGYDE*_9664-14K=4YV\2+;.FFU*YE"Q9J
M`+4#\-,V0,98^0^WV0V]V]>AMFK%,ZA2EJ7I`DN?&9^,#'APAL-A?E;C[N<C
M<.XVY[Q.SK9_)LXJ9=E46B,CPS<R/$<83),=G((V%%P8_`D?MTP+F/O>$=V+
M[2V_)UM1/W#I3M>WM\Q=FH2/WJ9N7OT0G;2]13.XKDFW\IQ#BR-("5DD$?UA
M&?'LX1,/60XCK#BW*FL4?R'4)+HC2BI"-`ESR0RW[/N:D^V=5(^I/307LS:+
MJR%V:W)*<,*9O'O^&)Y7=[O6I2]1*DT1^TM./LG&1_`@?_)ZC_X5G_R.N?\`
M`^SO_2*#_P#';_V8#^<W'^W_`.8O]<9L1&@==!_P?]_IQH;K4GS5"E#^:(&-
M0LB4*AI*1H`!_P!G]O1P*5+S&9@%2G%9JCGRY54UG5;_`.>M6;*RW/NGLCBM
M_D>*'*AV-%:AN$>.G\Z0A22/II]>OF-]2=IK-I]:MQOUB2ENLNSRTMX2<;4L
MG42"HB<SG(QZ@=#[S1[BZ;T-G;2EE^DI0V5`E1403,D$``XY3,&E\>V-UZ\2
MS_+$J=_=+;*XU'.1J4LLQ85'!DMQVT`C_P!W?FNI)[>9^XZ>G7K9_P#'YM>T
M6K8*]Q4"$TM54!)+29J"\)@E949992$4TZ\W:KI=TFSOH"V6UF2R<<<)R`^V
M+3GWCN:N8QBEK7+1.J*.>E4RN:CO277G%^08G2:UE*VI;<)I"`CS6-%`GMKU
M!WKFH=TW^[5%PO[ZZ';`0)4P"'D:DYN:DR6"O`RX0J]$:RTT5RT/I&LJ`"O-
MY4DS(`$YS,I^R(Q8=?87-LU55,:?9OS5J_;H3"#,F>?LI<?CK:;_`)S3SLE2
ME!)2$(20/(]>8&S]JO[LW$-M[+IS4W6H.A(_A:N`Q<*4=V?C%Z;QNVS6S;RE
MTCP)")GRJ3CV&8.0XQ(YQLX;S%SHF;[IIC,LQ84.95XE[FEBQ+6^7"<A4=&X
M[`]E/MM(]T/>2O(H*`%>JOIF]"^Z=G/O;GZE,FDNR7DEFCFPZEYN05J+[%2H
M-R.&DB>)GE%#]^=7[N]4+MM`TA3;D_Q-<Y</AT"<YYSPE$A&7;@8KM?$KY64
MW#==&LY46LJ8"4A:G)/@AIJ%6Q&$K<*$HT4KMHD=]>O2H;PVQMFD;M-[2BV/
M@:4H3S'I^*0H#WQ`#EK>KZA56MY0(,RF0/MQG/.')BN)EOK<25%EV.P^CS3X
M@AT%2%)]%'0$ZZZ:'IV(>17M(6EI*K>4ZD.:OB)X:<QAVQCBTJ2&2D>4YSBZ
M>AK=`2'_``3Y)406DK[)()\=5#Q7^BO5)[]#IIZ,"1:2?$QTEU"1(H!\8"#Y
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MN/5R-Q\,LY!2]6N+"EO>`*B-#IJ71;+U5L6XT0>4JD<04E)D!(YC*>,5FZF;
M1NSVZ?F[?:TO)2X"?Q`/&9.?&42^?'@[SI<Q7+\/YG[:;<;94>&UV`T&R<';
MK]I9B,T-?`MF+A$CV,SS%*7Z-4*L$/S5JVEHD^7EJ&S6)H62.2$@3RQ(D`))
MSRX>,62Z7W/<HV\;1<J4LNI;TI7S$D@$$8`"6`,LSD(`SF5Q6Y^8#SOL>;O$
MG%]O-S;>^P6%M^UBMY;T;-OCU2SBT2EESK^OR2[P:OE,6#S'N!<2U?<:';P/
M2E3U-O<IM*F4AXCXIGAV<,,HB'=NS=WV'=:MR6I]RK"I`M'EMB6G29J*B<1C
M@,.$&M\<.!<[<9J]R\AYGY1C=W_6US!M<`VUI'Z2-%VLF-2;V=?RYD"AIV8D
M*KN[!Q"HJTV=JZ64)4XZM3BE=(U35++ZEA9"I%/:=&6GV1*_3.BW79K6\BX.
MKJD/E2@E10@(U*U%/EG,#*?&4Y0*&]/QY9+O]\J3^ZN[FS<'.^)EGM`S5V\^
MYO8S%59954XE+BUC+\2GN8N5AQNZ6G1P(0T4]O#3OTHLWFOIVPRRZI+`$@,)
M3]W;$67GI#:-R;X_.[M0(>`QDHJD2,O,EP'/N&6,/WL]P%K../R+4^Y>P&R]
M9MMQX/&:\P^\G4UJT(LS<Z1E076(DUMG<V=Y(9CXS%:2EU/L@J.I\CW(MQW'
M<;E;TV^H<):3*>6,NX`9>WA#\V;TZM6PMQU-VM3(#3TR&A,);,B,%E:B9]XX
MQA?F1XG;V<H]FMGL4V'P*!G-QB.ZJ[S)ZB980H*F\:E8C>T\\Q)]Q:4P/YXL
MBPZ6WRXII90/74)-OK:ZWN!UM]9<"ISP&$I2R.7;''4+8[>^W&UE7RNE>I24
MIY@)D)3FI..$YXP"_*OX09>*9]M3NIP]K+BU3"W+Q6]S3:W([N%KA]>K*:VW
MER<&O9TEIB-14%2TN$Q5++I;::2?R5DZ!WN[NNU;2%#U0I!D1/#]41=3]"T6
M[J"UNBVU#A;0TVE3.A,O(3CKUS`/`8REWQ,?\A_'/,N5_&#<#9O")%3CU_>R
M\8EL3<KL)5=5PEXWDM-?_A+F5D6RUD36JY+:%%J0QJHES0=NFK;EU-.LN)J5
MI6OS)P'ED<9>W'.)*ZI[5K]QVM35.WRR-,ID')6J68$R0!GWSB#AC;OYI+?C
MH[P\M]A=H86T2]OXFT2K9N9A2[E./HBQ:^!=MRZ?<FX<7%0&?)Y_]K0Z6QJB
M(%=@Y0Y2U*U5-:=:S.<_OS$N&7;E$!UULWG7;<7L1NWABF>2E!?2ZA:D@+U3
MY>$]67QB0XQ/#PBX\YEQCX@[6[!YI,Q^]RW`Z&WBVLK#IDU_&[*RMLBO+Y+M
M59Y"S2RG4H_(:0XDL-);<2?L4#J&<H6]->FI0TD)0H$9X8S]L6DVAL2IL'23
M_`ZE\QPMK'-D`9J5J^'41A.4]7?$!'''8WYF>&KNZ>-\?]A]MY%!N5N@[ETJ
MVW`L]O\`))**Z#728%:8C<;<G&'H@?"TE25-.*3Z?QZ=-6U::JF0`A(*9S3B
M02<9GO'"*[[.HMZ=.D/[>ME%SVW*LO"I*FT*S/E#9"\/W@?")A]Q=IN6_+WX
MZ<JVCWFKMO\`;SDON%2QV+BF;DHBX376-%G=;;P4JF4,O))*TSJ:B#[:T>ZA
M#[J4+2IM*B45#-KIW%)*$J0H`<<./Z8E3=5!O/J#M46U]]VBJ5)Q4.6YB%3D
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M@_1%B.F.R*W:&TEV?2'@L`ZCI01*>$@I7;VQI?&OBGO7M_\`*[RSY*Y%@CE)
MM+N3@SE3AV8JN:5P9'86%IM+Y,*KH4F=912B/B<A22\TWJ$:$IUUZ+W*X5M?
M1)H><MMA`\H$B`?=[>/&$/9>R[A8M]56X"%.<Y<]!TI&*L/,"J?;E#%?+MPX
MY)\E.06P&XVRVS-!NOC6V^!9/`RRDRB_QZLIK2X1E#MA7T5O!EWV/3)==(;7
M_P`FU,84T`-5:]+.WKK6V=K2Q4*()!(P$S+/CG#-Z][1K]ZU#3]-0A+C(!4`
ML'5)1F"24RGE//LAU?BGVXYT;&Y+>[3;O<:]F]A./-C2WF7Q6]IVHB;%[=1^
MUH8!MK"9*W4W&<#%CC<5*#&0$)3^.%)5J2D)NY*BJNRE5514K-3I"4X"8$\L
M)#WB)*Z+U%?;*$6"HL;=*T")KYY7.0Q\O&<^"L(Q'RV<+N1?)2^V8S_9O&]O
M-PZ':M%C.O=E,V#34C,;>QLF'V)%:Y,%5^[UR:=IR)/AO7%='4TZ74I+J4D'
M]O7.LLK26VZI:G!,*,@-7><"!V0RNM/3NJNU]<7;Z<&G;TR(E,DS,P"K(9>W
MAQ@,^!7QX<R,1Y:;6;U9_M%L]QIQ':MZP_J["=L\C7'A[CPI3&5+C55,Q797
MN%+M+EV5=-N6HLK**AY5?$*&DA&KBC>=RW"Y49I7ZA?+5A+`SXXX#C"/TXV#
M56G<":]="A`3(RUB4AY0`0H\!EPR[(ZLJF+[S;WNNH#Z705H2$K<;;<0%,HE
M:(;0)B4ZAS37N!W/49EJK9/_`%"U@]J1]6)PBX954EM`:_Y=('PB2A[S&6_;
MD_\`I?\`V:?^[UDZK_C*]PCF=;_QU>X1DNNX$C[K(R(_N8W'J9N-%&=8I&0<
MJIXZHDV+X+6_<4\<*=899<"O;94T^?+50.HU'7F!Z\/3?6]0&$;_`-NH/S="
MW)8"5KF!BH@!02,.T$Q8?H/U&3M6Y&WW`Z*1U1TJ)2!,]I(.?"&]X`9#71,?
MW!PQU3J,AJ\F%S:0)32H*T/2ZV%#6S%][O,;0Y&*ENH'@CR\3W!Z.>@RLK[K
M:DT5R!IV[?IGJ`Q&F?W?M@;KZVQ>KNF\T1"T.ITX8R4"5`DX"1!D!VB)$#&9
ML4.QY@0_"\/8D1GV6G&'CX`N!M:TJ+C:O,#R!`)!_3KT:O-IVGOJVKH:YM%5
M2JU))2I0PR.(E%?Z:JJZ5D.H"TU:>PR.&4-_4[9;:8O>2LBH,(H*>Y>:6W^\
M0Z]N/,>6^HA48S2'$I*_4C3MZ]1;:>@'2S9E<+_9:8T=8A6HN+==<`.<]*E$
M2GP@R]NC<=8CY6J+A8,L)`>_M^V-0W>WEJ=KZV+#KX!RW-+4B-2X?5*38V$J
M<A2$+=E)84MZ)&CF2@K6[HGZI^O3>ZF=?Z#:3[.V;15,W'=%:@EI+6@%"4G3
MBVM)U3)!P.$+5MHW*X%;JPVE(Q5(@'+R]D^^,#L[MWG%M96.X.]4:I>SBR(_
M;:.N>784>,U*'O*,B.I9+;-SX'Q=4@`Z#3TZ9FT>CFX=[5G^+.IP4AXD+0VI
M*F3(B<_PE!.4N&$!7"MIT`,4<N6F8F<1A[<_;!718H9>3J2X6F"A#CA)=`<<
M*U()U\?$=@.W8#JU-K:?MZ!:6DJ_+&FTZ%9@D82F<21WPV'`3^(2)DQDNE:`
MXLK!E3\5QE(22OQ&BFTNCLH*!*%`I5H1KUT@A)U&!Z93:7@IP30/",:8RF62
M$AKWEH(4H!;/WI"O;\@RI)\05'73OWZPNN+,DX"`:ZXH;5)L33V3RCU4)XZE
M#J5M:%2&W$?D+2][SK@65.E6J0E0`'T\>W7"7W$F2IB-,HH*@AU]`4J<\_U<
M82>A/+0#(D.$DJU2R\_%4A+BHY<\2RM.BOY:RD_0J_3778=<)(3E'575TU,/
MP$R\?IPE":*QYM)$206V5)#98`U\4>ZI>K9]&5>V0DE.A[:]9S5ZI+G*!*>J
MI:I.I]$UD<3W8>V*VZU0;:2V^#[6B`5)+JD+2%AQSWG"7GRZHZ_S">ADU*6Y
MA<YD1U05C/+4$)\DR#CGC]7Z8\$)`D/!"HP=<!"9/XS0D-$Z'0%("%I]P:_<
M"3UA>\NN9EV0FHKJ?\QEI!.6<*QZPMN>\M;?EJI10AE'W.G5M+Y><\I!=#``
M]=-1^G7"JI)/=!MZG8>=+JAB84=K4NLACS'BWH62ZE,@^0U4%N![R!4E9U!&
MGIUKYD0%\E3]GZ8H77)5XM.>VN.>WLJ\RVEIM"D-(2SY>T/\2O(Z=QH.N2\N
M>I&4;0MBD=T@2PSBS71J_P`34@,N!DLMEHN!MA*4%MH1T%1]E(`25!/97B/T
M'72JE:DZ9$0IIK:92"AQ,T&7'OG]#%:ZEXS&91>2XIM+H`6TE;225*+*DMD^
M+#C*2`5H`6KT)TZY%4I*2E1,SPGG!)ABW(*G$MB9`XY'C[^^*E1'"H(6_H7-
M??\`!U](*_QT-A;)\_)G1U)/B/M(.I^[OUL(J"-:3]4%5W=E#X9`\@/=E/*+
M@1)!62\XVL)6KP7[*=0PM?VM^X?O\DH[>NA/?K0J5!.A)/,GE_D@>K:H'F4N
M%`U3&,_?[X256.N+;6Y)]SQ`*@IR1[;BPPRR/-GS]M;9\5**2-/(@^NO6DON
M`9&<"M/TK8&D81ZJGB!`0?M2EP/)1%_YD@K';Q=$?P+S:OJE6H/6@\^>WQ@C
M4_)*<YH1YAWPJN`74$%U"O,$._R4)+B25:(*4`(2$I.FH'EVZ[14.(D"#A"E
M35[(2!(2&0GD?IX1:FF6X$ID3'UMMD^"677(82V=/%!;C*0VX4!.@6H%?\>M
M<]>K`'$P!6_(U*N8I`$A//CVPNF`3[:VG4A(^U/\M)+;8"4EOR_\Z#IZKU/?
MUZ&%4A`*5#&!Z*L9--)*?)+*?$?3A"+4%'N/H:,9MQ1U$A$="'U)"R?;5X`(
M\?%2AJ!Y=P?7K"]I`6HDCLA-HZZG-:H!,R>^+I,-]*"/<25`-H4T"ZXRH`?S
MM6GE*3]R_0^NGKT#SCKU&<B9P>0Y3O.JYR022??";4!+9==?;8/D2OQ_&::*
MEZH(45-A).A;3_X(ZZ+RR9(),=U-32TK4V$A*NX_KA,U[SJBZT^6$O-^+Z6]
M0I9`*4D2@?R62T#V\%#7Z]:6\K)4]0CENIIZJC!=2"X>,\1W2RA1JL;8!2EY
M:BO3WB^M<HNZ`@(\WRIQI(4==4D$GUZX#STP9&0,%&ETM,[K:`![9Y1DX3'L
M(6/<#A6KRU"0G30:!/;NK3]3WZ$+BG!-8D8-O5"*DA2)2`B]ZY@&/NLC(^ZR
M,C`/I)6]^2MI!\U^/913^+J/+W/-!2/[M1TV]WIMSUF4FZ*::LV/.+DB".)$
M@L2TS^(>V#TW-*?DQ^)AGV]TC^F`CW(I,.N,Y85LQF=)B&^$.MD/Q$5M7:7-
M9<43<\JLH&2?M=1(A5[$B1[B5/*5[J/4`]5%JK5MA86YT(N="A8!YR`W4JF9
M9`T=/I'EG\1EX1(M)4WM-`IK<],\JW&4EJ4V%).$M(6O49F7W9YXQMK^>\G:
M]**^/L)CU[#8:90<AJMS:./52W2AOW7H5;;HK)XB)6HZ>^EE9((\=-"I,H]S
M^H*V6]5+T]VY47&M;)TO.O4:*9T]B4U%QIGA(SGS&T890'16?:M8^7ZNZT](
MU*9;<;J5.YG`%FE=;R_?\8U=S'^2V7S&Y%]GU!M'3)<8FFOVTH++,,K>;(2J
M32WTI=?9441U'^%3\7WT_5*B-.G.JB]25P:0]UAK=OT-B6V"MNU-W%54V")E
M"BRFH:*TC`E"EI*AY2H2,#7)_9#-/R+4Q6/.!8_$6MA*%=Z0?Q9<9*0G#,@Q
MONSL/9!G,\K1A=K2RMPD*81FB[5FX.9O31^5^.^^[D4"!(2TK1WW$Q6`R-1K
MV\>C'3FS^F>@W`3:KK<:W=Q<!3^:I>2L'":616T3"RB<L6U$=IG#0JG'U,.!
MIM81J.*2-/=/2H\()RN0T/<+;T)7=0>3`0$M>_Y$K4[[:3_/U['4Z_PZM>$U
M1IE"X*0*7[A9"I@?7A+L$H:__,<T%<I=F/\`)&3:&CRR5:GQ'V@+T`U.GJD#
M_3TH(Y@`"=/RNG#]J?&?\D&7#^&`!A/NBZZ[@"$W=2CL=#J-#W_U`GKI,IXY
M0"^%%LZ3(^/V1:NAS1/MJ8_C[@7Y?Z!KT*@MS\P/A*!&/D@B3V)[Y?ZV,*)"
M_`>2D>7;NV%Z?QU[$]<$HU8##OE`=0&C_P!.2/I^[%+H<\1[:F?IJ70K77Z_
M0'KI!;GYI^$H[8^5"1\QB>^7^M'J`OP^]3>NG8M!7]^O8GK2BC5Y09=\HYJ!
M3E/X!E[/^["2DJ^SV%MA'GW[+U*OKKXI_7HH0G4KF'&!J+Y8-$(F?9+_`"1[
MHUYGQ6CW]#J-#IK_``T3KZ]<R5IQ/X?C!1`H?FY@_BSRP_5]L7#8^Q/D4DZ=
MSW_\8:]!J3YC(B7C!]?Q&4Y17]OZIZYT_O#Z_P!4<X]\)J"_+[2SXZ?[0.O]
MWTZ.LZ`T`9D]T:/(_P![\?A'H!^I1K_#RT_[70GEX?9`)%//`F*_IZIU^GK_
M`*>B[@1K3/M@1.C3Y9Z8M"%^X/NC?3U!\NCHTZ?OP$?RW5YI<W_LQ<GR\>Q;
MUT&NNOCT3'+YY/=XP,.5IQ_A^$4Z+^I:_AIKIT/Y.^.3\OPG]44J#FA[L?W@
M_P"GK8Y<_O1U_P`I][+PCU(7V\BSZ?[`/6'1PG'"OE3\.'N^R*_UU*=-._KZ
M?7Z=<X1Q)B1Q,I1:E*]6_:6W[>O;LO4_V^*=.BTDXZSYH,TORP8DWBF7='WB
MWJKVEH]W0Z]CH/7731.OKUJ2I#6?)XP1IA0BI)09N=F'ZH60'/'[E-ZZ>J`K
M77^/;7HX>7/"<N^4&*CE$'E3"Y_3*/%!7MG12"K_`-8%::=O34`];!1JQ&'=
M*`*8,C_J3,=__>$5,A7MI\BV5:=_#R\--?IJ/TZTO1J,LN^4X,*^7UDLSY?=
M*7U81]HO]6-/X@]9Y.^,_P"5EC]D*MZZ=R@]_P#8]/[^N52X3C8Y4OPLH4ZY
$C(__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
